| Target Name | Substrate Name | Enz. Inhib. Data |
| 11-beta-Hydroxysteroid Dehydrogenase 1 (11-beta-HSD1) |
cortisone |
73 |
| [3H]-cortisone |
159 |
| [3H]cortisone |
26 |
| 11-beta-Hydroxysteroid Dehydrogenase 2 (11-beta-HSD2) |
cortisol |
42 |
| [3H]cortisol |
11 |
| 15-Lipoxygenase |
Linoleic Acid |
115 |
| 17-beta-Hydroxysteroid Dehydrogenase 1 (17-beta-HSD1) |
17beta-estradiol (E2) |
3 |
| Estrone (E1) |
3 |
| [2,4,6,7-3H]-E1 |
39 |
| 17-beta-Hydroxysteroid Dehydrogenase 2 (17-beta-HSD2) |
[2,4,6,7-3H]-E2 |
16 |
| 17-beta-Hydroxysteroid Dehydrogenase 5 (17-beta-HSD5, AKR1C3) |
3alpha-Androstanediol |
2 |
| Androstenedione |
3 |
| Androsterone |
2 |
| S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| testosterone |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (H222S) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L306A) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L308A) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 20-alpha-Hydroxysteroid Dehydrogenase (AKR1C1) Mutant (L54V) |
5Beta-pregnane-3alpha,20alpha-diol |
1 |
| 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase (IspF) |
Not Available |
9 |
| 3-alpha-Hydroxysteroid Dehydrogenase Type 1 (AKR1C4) |
S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| 3-alpha-Hydroxysteroid Dehydrogenase Type 3 (AKR1C2) |
S-(+)-1,2,3,4-tetrahydro-1-naphthol |
1 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) |
AKT2 |
75 |
| PDK1 Peptide Substrate |
1 |
| PDKtide |
11 |
| SGK1 |
50 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (A162V) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (E166D) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (L159M) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (T222A) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (V143T) |
PDKtide |
2 |
| 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Mutant (V143T/T222A) |
PDKtide |
2 |
| 3C-like protease |
to-be-curated |
101 |
| 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) |
5'-methylthioadenosine (MTA) |
3 |
| 5-HT-S1A |
to-be-curated |
1 |
| 5-HT-S2 |
to-be-curated |
8 |
| 5-HT1 |
to-be-curated |
36 |
| 5-HT1 like |
to-be-curated |
1 |
| 5-HT1DBeta |
to-be-curated |
2 |
| 5-HT2 |
to-be-curated |
248 |
| 5-HT4a |
to-be-curated |
7 |
| 5-HT4b |
to-be-curated |
8 |
| 5-HT4c |
to-be-curated |
8 |
| 5-HT4d |
to-be-curated |
8 |
| 5-HT5 |
to-be-curated |
17 |
| 5-HT5B |
to-be-curated |
78 |
| 5-HT7b |
to-be-curated |
16 |
| 5-HT7L |
to-be-curated |
58 |
| 5-HT7S |
to-be-curated |
20 |
| 5-hydroxytryptamine (serotonin) receptor 2B [Homo sapiens] |
to-be-curated |
1 |
| 5-Lipoxygenase |
Arachidonic acid |
74 |
| Linoleic Acid |
28 |
| AAK1 |
to-be-curated |
12 |
| Abhydrolase Domain-Containing Protein 6 |
FP-rhodamine |
1 |
| ABL |
Biotinylated peptide substrate |
14 |
| biotinylated SB202190 |
7 |
| [Val5]-Angiotensin II |
30 |
| ABL Mutant (E255K) |
biotinylated SB202190 |
7 |
| ABL Mutant (F359V) |
biotinylated SB202190 |
7 |
| ABL Mutant (H396P) |
biotinylated SB202190 |
7 |
| ABL Mutant (M351T) |
biotinylated SB202190 |
7 |
| ABL Mutant (Q252H) |
biotinylated SB202190 |
7 |
| ABL Mutant (T315I) |
biotinylated affinity ligand |
20 |
| biotinylated SB202190 |
7 |
| ABL Mutant (T315N) |
biotinylated SB202190 |
7 |
| ABL Mutant (Y253F) |
biotinylated SB202190 |
7 |
| ABL1 |
to-be-curated |
20 |
| ABL1(E255K) |
to-be-curated |
15 |
| ABL1(H396P) |
to-be-curated |
17 |
| ABL1(M351T) |
to-be-curated |
18 |
| ABL1(Q252H) |
to-be-curated |
18 |
| ABL1(Y253F) |
to-be-curated |
18 |
| ABL2 |
to-be-curated |
15 |
| acetyl-CoA acetyltransferase/HMG-CoA reductase |
to-be-curated |
3 |
| Acetylcholinesterase (AChE) |
acetylcholine |
93 |
| acetylcholine chloride |
15 |
| acetylthiocholine chloride |
15 |
| acetylthiocholine iodide |
873 |
| Activated Protein C (APC) |
Chromogenic Substrate S-2366 |
1 |
| ACVR1 |
to-be-curated |
7 |
| ACVR1B |
to-be-curated |
5 |
| ACVR2A |
to-be-curated |
2 |
| ACVR2B |
to-be-curated |
6 |
| ACVRL1 |
to-be-curated |
2 |
| Acyl Cholesterol Acyltransferase 1 (ACAT-1) |
[14C] oleoyl coenzyme A |
7 |
| ADAMTS-4 (Aggrecanase-1) |
Fluorescent peptide WAAG-3R |
30 |
| ADAMTS-5 (Aggrecanase-2) |
QF-peptide |
30 |
| WAAG-3R |
35 |
| ADCK3 |
to-be-curated |
5 |
| ADCK4 |
to-be-curated |
6 |
| ADENOSINE |
to-be-curated |
1 |
| ADENOSINE A1 high |
to-be-curated |
28 |
| ADENOSINE A1 low |
to-be-curated |
28 |
| ADENOSINE A2 |
to-be-curated |
110 |
| Adenosine A3 Receptor |
[3H]AB-MECA |
29 |
| Adenosine Deaminase |
Adenosine |
59 |
| Adenosine Kinase (AK) |
Adenosine |
8 |
| Adenosine Phosphosulfate Reductase (APSR) |
Adenosine Phosphosulfate (APS) |
10 |
| Adenosine Receptor A1 |
Not Available |
71 |
| [3H]DPCPX |
103 |
| Adenosine Receptor A2A |
[3H]-CGS 21680 |
71 |
| [3H]-ZM241385 |
86 |
| [3H]NECA |
29 |
| Adenosine Receptor A2B |
Not Available |
7 |
| Adenosine Receptor A3 |
Not Available |
7 |
| Adenylate cyclase |
to-be-curated |
7 |
| Adenylate cyclase Forskolin |
to-be-curated |
1 |
| ADORA1 |
to-be-curated |
251 |
| ADORA2A |
to-be-curated |
73 |
| ADORA2B |
to-be-curated |
3 |
| ADORA3 |
to-be-curated |
78 |
| ADRA1A |
to-be-curated |
57 |
| ADRA1B |
to-be-curated |
47 |
| ADRA2A |
to-be-curated |
162 |
| ADRA2B |
to-be-curated |
141 |
| ADRA2C |
to-be-curated |
140 |
| ADRB1 |
to-be-curated |
83 |
| ADRB2 |
to-be-curated |
208 |
| Adrenaline alpha1 |
to-be-curated |
1 |
| Adrenaline alpha2 |
to-be-curated |
1 |
| Adrenergic Alpha |
to-be-curated |
231 |
| adrenergic Alpha1 |
to-be-curated |
313 |
| adrenergic Alpha1C |
to-be-curated |
21 |
| adrenergic Alpha2 |
to-be-curated |
405 |
| adrenergic Alpha2D |
to-be-curated |
26 |
| adrenergic Beta1,2 |
to-be-curated |
9 |
| Adrenergic, alpha-2B-, receptor [Homo sapiens] |
to-be-curated |
1 |
| adrenergic, alpha-2C-, receptor [Homo sapiens] |
to-be-curated |
1 |
| Agp1p |
to-be-curated |
23 |
| AGTR1 |
to-be-curated |
8 |
| AICAR Tfase |
AICAR |
19 |
| AKT1 |
to-be-curated |
2 |
| AKT1 |
to-be-curated |
18 |
| AKT2 |
to-be-curated |
3 |
| AKT3 |
to-be-curated |
2 |
| Aldehyde Reductase (ALR1) |
D,L-glyceraldehyde |
40 |
| Aldose Reductase (ALR2) |
benzyl alcohol |
15 |
| D,L-glyceraldehyde |
50 |
| D-glyceraldehyde |
77 |
| D-xylose |
4 |
| xylitol |
10 |
| Aldose Reductase (ALR2) Mutant (C298A) |
benzyl alcohol |
2 |
| Aldose Reductase (ALR2) Mutant (C298A/W219Y) |
xylitol |
12 |
| Aldosterone Synthase (CYP11B2) |
deoxycorticosterone |
94 |
| [4-14C]-11-deoxycorticosterone |
16 |
| ALK2 (BMPR-I) |
poly(Glu4, Tyr) |
7 |
| ALK5 (TGFβR-I) |
poly(Glu4, Tyr) |
5 |
| Alkaline phosphatase, intestinal |
to-be-curated |
600 |
| alkaline phosphatase, placental-like preproprotein |
to-be-curated |
359 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor |
to-be-curated |
359 |
| Alpha-1 Adrenergic Receptor |
[3H]-Prazosin |
12 |
| alpha-2A adrenergic receptor [Homo sapiens] |
to-be-curated |
1 |
| alpha-Amylase |
Potato starch |
20 |
| alpha-Carbonic Anhydrase |
Carbon Dioxide |
17 |
| alpha-Chymotrypsin |
Not Available |
1 |
| alpha-Glucosidase (alpha-Glu) |
4-methylumbelliferyl alpha-glucoside |
14 |
| pNPG |
21 |
| alpha-Methylacyl-CoA Racemase |
(25S)-THC-CoA |
10 |
| Alpha2 Adrenoreceptor |
Clonidine |
4 |
| Alpi |
to-be-curated |
361 |
| alternatively spliced Trp4 |
to-be-curated |
27 |
| Aminopeptidase M |
L-alanyl-p-nitroanilide |
27 |
| L-Leucine-para-nitroanilide |
19 |
| AMP-activated protein kinase (AMPK) |
poly(Glu4, Tyr) |
6 |
| AMPK-alpha1 |
to-be-curated |
9 |
| AMPK-alpha2 |
to-be-curated |
7 |
| Androgen Receptor (AR) |
DHT |
167 |
| Not Available |
27 |
| SRC2-3 peptide |
11 |
| Testosterone |
11 |
| [3H]DHT |
49 |
| [3H]MIB |
70 |
| ANF |
to-be-curated |
1 |
| Angiotensin |
to-be-curated |
1 |
| Angiotensin II AT1 |
to-be-curated |
1 |
| Angiotensin II AT2 |
to-be-curated |
3 |
| Angiotensin II, central |
to-be-curated |
42 |
| Angiotensin-Converting Enzyme |
Abz-Gly-p-nitro-Phe-Pro-OH |
6 |
| Mca-Ala-Ser-Asp-Lys-Dpa-OH |
4 |
| N-Cbz-Phe-His-Leu |
29 |
| Angiotensin-Converting Enzyme 2 |
Mca-APK(Dnp)OH |
36 |
| ANKK1 |
to-be-curated |
9 |
| Anthrax Lethal Factor (LF) |
fluorogenic LF protease substrate III |
21 |
| Fluorogenic LF Substrate |
28 |
| MAPKKide |
147 |
| Peptide Substrate |
50 |
| apelin receptor |
to-be-curated |
481 |
| Apoptosis Regulator Bcl-2 |
FITC-conjugated-Bim BH3 Peptide |
10 |
| Fluorescein-labeled BAX peptide |
52 |
| Apoptosis regulator Bcl-2. |
to-be-curated |
104 |
| Apoptosis regulator Bcl-B (Bcl-2-like 10 protein) (Bcl2-L-10) (Anti-apoptotic protein NrH). |
to-be-curated |
87 |
| Apoptosis Regulator Bcl-xL |
Bak-BH3 peptide |
19 |
| F-BakBH3 |
10 |
| F-Bim |
78 |
| Fl-Bak peptide |
50 |
| Fluorescein-labeled BAD peptide |
52 |
| Apoptotic peptidase activating factor 1 |
to-be-curated |
1034 |
| Apurinic-Apyrimidinic Endonuclease 1 (APE1) |
DNA Substrate |
47 |
| Arg-vasopressin V1 |
to-be-curated |
1 |
| ARK5 |
to-be-curated |
8 |
| Aromatase (CYP19) |
Androstenedione |
279 |
| dibenzylfluorescein (DBF) |
21 |
| Testosterone |
60 |
| [1beta-3H] androstenedione |
53 |
| Arrestin, beta 1 |
to-be-curated |
1 |
| Aryl Hydrocarbon Receptor (AhR) |
[3H]-TCDD |
25 |
| aryl hydrocarbon receptor precursor |
to-be-curated |
126 |
| Asparaginyl Endopeptidase (AE) |
Cbz-Ala-Ala-Asn-AMC |
89 |
| ATP Phosphoribosyltransferase |
Phosphoribosyl Pyrophosphate (PRPP) |
11 |
| ATP-Binding Cassette Transporter ABCG2 |
PhA |
21 |
| ATP-binding cassette, sub-family C, member 1 isoform 1 |
to-be-curated |
803 |
| ATP-binding cassette, sub-family G, member 2 |
to-be-curated |
24 |
| ATP-dependent clamp loaders gp44/62 |
2'-deoxyadenosine triphosphate |
13 |
| ATP-dependent clamp loaders gp44/62 (R175K) |
2'-deoxyadenosine triphosphate |
7 |
| ATP-dependent clamp loaders gp44/62 (R175L) |
2'-deoxyadenosine triphosphate |
7 |
| Aurora Kinase A (Aurora-A) |
Aurora Peptide Substrate |
23 |
| biotinylated affinity ligand |
11 |
| Biotinylated Cross-tide Substrate |
13 |
| Biotinylated Peptide Substrate |
47 |
| CHOCKtide |
131 |
| FAM-PKAtide |
26 |
| Histone H3 |
84 |
| Kemptide |
1 |
| Not Specified |
1 |
| PKAtide |
2 |
| Substrate Peptide SerThr 01 |
1 |
| Aurora Kinase B (Aurora-B) |
Aurora B Substrate Peptide |
1 |
| biotinylated affinity ligand |
13 |
| Biotinylated Cross-tide Substrate |
13 |
| Biotinylated Peptide Substrate |
37 |
| CHOCKtide |
6 |
| FAM-PKAtide |
13 |
| Histone H3 |
16 |
| Not Specified |
1 |
| Aurora Kinase C (Aurora-C) |
biotinylated affinity ligand |
18 |
| Not Specified |
1 |
| AVPR1A |
to-be-curated |
18 |
| AVPR1B |
to-be-curated |
10 |
| AVPR2 |
to-be-curated |
32 |
| AXL Receptor Tyrosine Kinase |
biotinylated affinity ligand |
16 |
| B-cell leukemia/lymphoma 2 related protein A1a |
to-be-curated |
187 |
| B-Raf Protein Kinase |
biotin-MEK |
1 |
| GST-MEK |
38 |
| GST-MEK1 |
16 |
| MEK-1 |
1 |
| Rhodamine green labeled ligand |
17 |
| B-Raf Protein Kinase Mutant (V599E) |
MEK-1 |
1 |
| B-Raf Protein Kinase Mutant (V600E) |
biotin-MEK |
13 |
| GST-MEK1 |
101 |
| MEK Inactive Mutant |
32 |
| Bacterial Leucyl Aminopeptidase |
L-Leucine-para-nitroanilide |
19 |
| Bacteriophage T4 DNA Ligase |
32P-labeled nicked duplex DNA substrate |
7 |
| bcl-2-related protein A1 |
to-be-curated |
353 |
| Bcl-w |
to-be-curated |
138 |
| bcl-xL |
to-be-curated |
5 |
| BCL2-like 1 isoform 1 |
to-be-curated |
128 |
| BCL2-like 11 isoform 1 |
to-be-curated |
1065 |
| BCL2-related protein A1 |
to-be-curated |
30 |
| BDKRB1 |
to-be-curated |
4 |
| BDKRB2 |
to-be-curated |
1 |
| Benzodiazepine central |
to-be-curated |
4 |
| Benzodiazepine peripheral |
to-be-curated |
1 |
| Beta lactamase |
to-be-curated |
574 |
| Beta-1 Adrenergic Receptor |
[3H]CGP 12177 |
25 |
| Beta-2 Adrenergic Receptor |
[125I]-(-)iodopindolol |
7 |
| [3H]CGP 12177 |
32 |
| beta-2 adrenergic receptor |
to-be-curated |
134 |
| Beta-3 Adrenergic Receptor |
[3H]CGP 12177 |
25 |
| beta-adrenergic receptor kinase 1 |
to-be-curated |
41 |
| beta-Carbonic Anhydrase |
Carbon Dioxide |
37 |
| Beta-glucocerebrosidase |
p-Nitrophenyl beta-D-glucopyranoside |
6 |
| Beta-hexosaminidase subunit beta (Hex B) |
MUG |
6 |
| beta-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) |
crotonoyl-CoA |
53 |
| beta-Ketoacyl-ACP Synthase III (FabH) |
Malonyl-ACP |
58 |
| beta-lactamase |
to-be-curated |
93 |
| Beta-mannosidase |
2,4-dinitrophenyl-b-D-mannopyranoside, 17 |
5 |
| beta-Secretase (BACE-1) |
APP_NFEV |
23 |
| BACE Peptide Substrate |
62 |
| BACE Substrate Peptide |
85 |
| BACE-1 Peptide Substrate |
16 |
| BACE-1 Substrate Peptide |
47 |
| ELGY-9 |
7 |
| Fluorescent Substrate |
110 |
| fluorescent substrate FS-2 |
7 |
| Fluorogenic Substrate |
37 |
| FS1 FRET Substrate |
4 |
| MBPAPPC125 |
30 |
| beta-Secretase (BACE-2) |
BACE Peptide Substrate |
5 |
| BACE Substrate Peptide |
7 |
| Fluorescent Substrate |
100 |
| Fluorogenic Substrate |
12 |
| Bfl-1 |
F-Bim |
198 |
| FITC-conjugated-Bim BH3 Peptide |
8 |
| Bfl-1 |
FITC-Ahx-EDIIRNIARHLAQVGDSMDR |
44 |
| BHE |
to-be-curated |
23 |
| BIKE |
to-be-curated |
12 |
| Biotin Carboxylase |
Biotinyl-BCCP |
14 |
| BLK |
to-be-curated |
20 |
| BMPR1A |
to-be-curated |
1 |
| BMX |
to-be-curated |
7 |
| Bombesin |
to-be-curated |
2 |
| Bone morphogenetic protein |
poly(Glu4, Tyr) |
31 |
| Bone Morphogenetic Protein Receptor type II (BMPR2) |
biotinylated affinity ligand |
6 |
| Botulinum Neurotoxin Type A |
SNAP-25 substrate peptide |
18 |
| SNAP-25-based peptide substrate |
16 |
| SNAPtide |
99 |
| BRAF |
to-be-curated |
10 |
| BRAF(V600E) |
to-be-curated |
10 |
| BRSK1 |
to-be-curated |
5 |
| BRSK2 |
to-be-curated |
5 |
| BTK |
to-be-curated |
6 |
| Butyrylcholinesterase (BChE) |
Benzoylcholine Chloride |
4 |
| Butyrylcholinesterase (BuChE) |
butyrylthiocholine |
603 |
| butyrylthiocholine chloride |
28 |
| BZLF1 |
to-be-curated |
127 |
| BZLF2 |
to-be-curated |
835 |
| C-C chemokine receptor type 6 |
to-be-curated |
302 |
| C-Raf Protein Kinase |
MEK Inactive Mutant |
34 |
| calcineurin |
to-be-curated |
1 |
| calcineurin A1, putative; calmodulin-binding protein 1, putative; serine/threonine-protein phosphatase 2B catalytic subunit A1, putative |
to-be-curated |
51 |
| Calcium channel |
to-be-curated |
84 |
| Calcium channel (DHP) |
to-be-curated |
4 |
| Calcium channel (Type L) |
to-be-curated |
1 |
| Calcium channel (Type N) |
to-be-curated |
3 |
| Calcium channel (Type T,L) |
to-be-curated |
3 |
| Calcium channel (VER) |
to-be-curated |
8 |
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
to-be-curated |
367 |
| Calcium-Sensing Receptor (CaSR) |
Not Available |
44 |
| calpain |
to-be-curated |
1 |
| Calpain-1 |
BODIPY FL casein |
10 |
| Suc-Leu-Tyr-AMC |
11 |
| Calpain-2 |
BODIPY FL casein |
10 |
| CaM Kinase II |
Autocamtide-2 |
38 |
| CaM Kinase II Peptide Substrate |
4 |
| CAMK1 |
to-be-curated |
7 |
| CAMK1D |
to-be-curated |
6 |
| CAMK1G |
to-be-curated |
5 |
| CAMK2A |
to-be-curated |
6 |
| CAMK2B |
to-be-curated |
4 |
| CAMK2D |
to-be-curated |
5 |
| CAMK2G |
to-be-curated |
5 |
| CAMK4 |
to-be-curated |
5 |
| CAMKK1 |
to-be-curated |
10 |
| CAMKK2 |
to-be-curated |
9 |
| cAMP-Dependent Protein Kinase (PKA) |
biotinylated kemptide |
30 |
| Fluorescent probe ARC-583 |
27 |
| histone (type H IIas) |
15 |
| histone (type Vs) |
61 |
| Histone H1 |
10 |
| Histone type HL |
67 |
| Histone VII-S |
13 |
| ING Peptide |
16 |
| Kemptide |
81 |
| Lys-rich histone |
97 |
| Peptide Substrate |
11 |
| PKA Peptide Substrate |
5 |
| PKA-specific peptide substrate |
21 |
| stathmin |
1 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (2) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (3) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR1 (4) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (2) |
Kemptide |
1 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR2 (3) |
Kemptide |
3 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR3 |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR3 (1) |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR4 |
Kemptide |
5 |
| cAMP-Dependent Protein Kinase (PKA) Mutant PKAR5 |
Kemptide |
5 |
| cAMP-dependent protein kinase catalytic subunit alpha isoform 1 |
to-be-curated |
94 |
| cAMP-dependent protein kinase type I-alpha regulatory subunit |
to-be-curated |
19 |
| cAMP-dependent protein kinase type II-beta regulatory subunit |
to-be-curated |
19 |
| Candida albicans strain ATCC 10261 multidrug efflux pump (MDR1) gene, MDR1-A allele, complete cds |
to-be-curated |
31 |
| Cannabinoid Receptor 1 |
GTP-gamma-S |
19 |
| [3H]CP55940 |
109 |
| [3H]SR141716A |
44 |
| Cannabinoid receptor 1 (brain) |
to-be-curated |
172 |
| Cannabinoid Receptor 2 |
[3H]CP55940 |
122 |
| [3H]SR141716A |
10 |
| cannabinoid receptor 2 |
to-be-curated |
256 |
| Carbonic Anhydrase (hpCA) |
Carbon Dioxide |
47 |
| Carbonic Anhydrase (mtCA 1) |
Carbon Dioxide |
37 |
| Carbonic Anhydrase (mtCA 3) |
Carbon Dioxide |
37 |
| Carbonic anhydrase 1 (CA I) |
4-Nitrophenylacetate |
8 |
| Carbonic anhydrase 2 |
to-be-curated |
12 |
| Carbonic anhydrase 2 (CA II) |
4-Nitrophenylacetate |
8 |
| Carbonic Anhydrase 2 (Can2) |
Carbon Dioxide |
37 |
| Carbonic Anhydrase I |
4-nitrophenyl acetate |
139 |
| Carbon Dioxide |
315 |
| dansylamide |
5 |
| Carbonic Anhydrase II |
4-nitrophenyl acetate |
173 |
| Carbon Dioxide |
401 |
| dansylamide |
52 |
| Carbonic anhydrase II (CAII) |
4-Nitrophenyl Acetate |
5 |
| Carbonic Anhydrase II Mutant (F131V) |
dansylamide |
11 |
| Carbonic Anhydrase III |
Carbon Dioxide |
49 |
| Carbonic Anhydrase IV |
4-nitrophenyl acetate |
133 |
| Carbon Dioxide |
134 |
| Carbonic Anhydrase IX |
Carbon Dioxide |
265 |
| Carbonic Anhydrase VA |
Carbon Dioxide |
149 |
| Carbonic Anhydrase VB |
Carbon Dioxide |
103 |
| Carbonic Anhydrase VI |
Carbon Dioxide |
85 |
| Carbonic Anhydrase VII |
Carbon Dioxide |
52 |
| Carbonic Anhydrase XII |
Carbon Dioxide |
69 |
| Carbonic Anhydrase XIII |
Carbon Dioxide |
51 |
| Carbonic Anhydrase XIV |
Carbon Dioxide |
53 |
| Carbonic Anhydrase XV |
Carbon Dioxide |
73 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 |
to-be-curated |
1011 |
| Carboxylesterase 1 |
Nitrophenyl Acetate |
271 |
| Carboxylesterase 2 (intestine, liver) |
Nitrophenyl Acetate |
146 |
| Carboxypeptidase A (CPA) |
Furylacryloyl-Phe-Phe |
15 |
| cardiac alpha tropomyosin |
to-be-curated |
276 |
| Casein Kinase I |
Casein |
8 |
| CK1 Peptide Substrate |
4 |
| CK1 Substrate Peptide |
1 |
| Casein Kinase II |
CK-2 Peptide Substrate |
15 |
| CK2 Peptide Substrate |
1 |
| Peptide Substrate |
25 |
| stathmin |
1 |
| caspase 7, apoptosis-related cysteine peptidase |
to-be-curated |
42 |
| Caspase-1 |
Caspase-1 Fluorogenic Substrate |
115 |
| Caspase-1 Fluorogenic Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-1 Substrate |
20 |
| Fluorometric Tetrapeptide Ac-DEVD-AMC |
1 |
| caspase-1 isoform alpha precursor |
to-be-curated |
41 |
| Caspase-2 |
Caspase Substrate |
7 |
| Caspase-2 Fluorogenic Substrate |
8 |
| Caspase-2 Fluorogenic Substrate Ac-Val-Asp-Val-Ala-Asp-AFC |
9 |
| Caspase-3 |
Ac-DEVD-AFC |
42 |
| Caspase Fluorogenic Substrate |
188 |
| Caspase-3 (7) Fluorogenic Substrate |
14 |
| Caspase-3 Fluorogenic Substrate |
35 |
| Caspase-3 Fluorogenic Substrate Ac-Asp-Glu-Val-Asp-AFC |
49 |
| Caspase-3 Substrate |
73 |
| Fluorometric Tetrapeptide Ac-DEVD-AMC |
1 |
| caspase-3 preproprotein |
to-be-curated |
746 |
| Caspase-4 |
Caspase-4 Fluorogenic Substrate |
8 |
| Caspase-4 Fluorometric Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-5 |
Caspase-5 Fluorometric Substrate Ac-Trp-Glu-His-Asp-AFC |
9 |
| Caspase-6 |
Caspase Fluorogenic Substrate |
8 |
| Caspase Substrate |
7 |
| Caspase-6 Fluorogenic Substrate |
29 |
| Caspase-6 Fluorometric Substrate Ac-Val-Glu-Ile-Asp-AFC |
9 |
| Caspase-6 Substrate |
22 |
| Caspase-7 |
Caspase Fluorogenic Substrate |
85 |
| Caspase Substrate |
7 |
| Caspase-3 (7) Fluorogenic Substrate |
11 |
| Caspase-7 Fluorometric Substrate Ac-Asp-Glu-Val-Asp-AFC |
9 |
| Caspase-7 Substrate |
20 |
| Caspase-8 |
Caspase Substrate |
7 |
| Caspase-8 Fluorogenic Substrate |
96 |
| Caspase-8 Fluorometric Substrate Ac-Ile-Glu-Thr-Asp-AFC |
9 |
| Caspase-8 Substrate |
20 |
| Caspase-9 |
Caspase-9 Fluorogenic Substrate |
8 |
| caspase-9 isoform alpha preproprotein |
to-be-curated |
425 |
| Cathepsin B |
Boc-Leu-Lys-Arg-AMC |
100 |
| Cbz-Phe-Arg-AMC |
36 |
| DCG04 |
6 |
| Fluorogenic Substrate |
3 |
| Z-Arg-Arg-AMC |
24 |
| Z-Phe-Arg-NMec |
13 |
| Cathepsin B |
to-be-curated |
102 |
| Z-Arg-Arg-AMC |
56 |
| Cathepsin B-Like Cysteine Protease (TbcatB) |
Z-Phe-Arg-AMC |
56 |
| Cathepsin D |
Cathepsin D FRET Substrate |
1 |
| Cathepsin D Peptide Substrate |
57 |
| Cathepsin D/Pepsin Peptide Substrate |
5 |
| Fluorescent Substrate |
100 |
| MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH2 |
27 |
| Peptide Substrate |
104 |
| Cathepsin G |
to-be-curated |
93 |
| Cathepsin H |
DCG04 |
4 |
| Cathepsin K |
Ac-Lys-His-Pro-Lys-ACMC |
170 |
| Cbz-Leu-Arg-AMC |
173 |
| Cbz-Phe-Arg-AMC |
114 |
| Z-Leu-Arg-NHMec |
48 |
| Z-Phe-Arg-AMC |
24 |
| Cathepsin L |
Ac-His-Lys-Phe-Lys-ACMC |
170 |
| Cbz-Leu-Arg-AMC |
100 |
| Cbz-Phe-Arg-AMC |
87 |
| Cbz-Phe-Arg-MCA |
13 |
| Fluorogenic Substrate |
3 |
| Z-Phe-Arg-AMC |
24 |
| Z-Phe-Arg-NHMec |
52 |
| cathepsin L preproprotein |
to-be-curated |
344 |
| cathepsin L1 |
to-be-curated |
242 |
| Cathepsin L2 |
Z-Phe-Arg-AMC |
24 |
| Cathepsin S |
Ac-His-Pro-Val-Lys-ACMC |
180 |
| Cathepsin S Substrate Peptide |
28 |
| Cbz-Leu-Arg-AMC |
8 |
| Cbz-Phe-Arg-AMC |
9 |
| Z-Leu-Leu-Arg-AMC |
43 |
| Z-Phe-Arg-AMC |
24 |
| Z-Val-Val-Arg-AMC |
130 |
| Z-Val-Val-Arg-NHMec |
48 |
| cathepsin S preproprotein |
to-be-curated |
129 |
| Cathepsin V |
Cbz-Phe-Arg-AMC |
2 |
| Cathepsin Z |
DCG04 |
3 |
| CCKBR |
to-be-curated |
77 |
| Cdc7 Kinase |
His6-tagged MCM2 |
16 |
| MCM2 |
85 |
| CDK2 |
to-be-curated |
6 |
| CDK3 |
to-be-curated |
5 |
| CDK5 |
to-be-curated |
7 |
| Cell Division Cycle 2-Like 1(CDC2L1) |
biotinylated affinity ligand |
7 |
| Cell Division Cycle 2-Like 2 (CDC2L2) |
biotinylated affinity ligand |
7 |
| Cell Division Cycle 2-Like 6 (CDK11) |
biotinylated affinity ligand |
11 |
| cell division cycle 25B isoform 2 |
to-be-curated |
310 |
| cell division cycle 42 (GTP binding protein, 25kDa) |
to-be-curated |
581 |
| cGMP-Dependent Protein Kinase |
Histone H1 |
10 |
| Histone II-A |
13 |
| CGRP |
to-be-curated |
1 |
| Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid |
to-be-curated |
8 |
| Chain A, Crystal Structure Of A Pantothenate Synthetase, Apo Enzyme In C2 Space Group |
to-be-curated |
148 |
| Chain B, Rna Aptamer Complexed With Hiv-1 Rev Peptide, Nmr, 7 Structures |
to-be-curated |
28 |
| Checkpoint Kinase (Chk1) |
biotinylated CDC25C peptide |
13 |
| biotinylated cdc25c peptide substrate |
2 |
| biotinylated CHKtide |
9 |
| Biotinylated Peptide Substrate |
24 |
| Cdc25C peptide substrate |
124 |
| Chktide |
31 |
| Not Available |
1 |
| Synthetic Chk1 Peptide Substrate |
3 |
| Checkpoint Kinase (Chk2) |
biotinylated CDC25C peptide |
4 |
| Fam-CHK2tide |
7 |
| Histone H1 |
4 |
| CHEK1 |
to-be-curated |
7 |
| Chitinase |
fluorogenic substrate |
12 |
| Not Available |
3 |
| Chitinase Mutant (A217G) |
Not Available |
3 |
| Chitinase Mutant (D175A) |
Not Available |
3 |
| Chitinase Mutant (D246A) |
Not Available |
1 |
| Chitinase Mutant (E177A) |
Not Available |
1 |
| Chitinase Mutant (E322A) |
Not Available |
3 |
| Chitinase Mutant (M243A) |
Not Available |
3 |
| Chitinase Mutant (R301K) |
Not Available |
3 |
| Chitinase Mutant (T138A) |
Not Available |
3 |
| Chitinase Mutant (Y245F) |
Not Available |
2 |
| Chloride channel, TBOB |
to-be-curated |
3 |
| Cholecystokinin |
to-be-curated |
76 |
| Cholecystokinin B |
to-be-curated |
110 |
| Cholecystokinin central |
to-be-curated |
3 |
| Cholecystokinin peripheral |
to-be-curated |
3 |
| Cholecystokinin-1 Receptor |
[125I]CCK-8 |
17 |
| Cholecystokinin-2 Receptor |
[125I]CCK-8 |
17 |
| Choline Uptake |
to-be-curated |
1 |
| Cholinergic receptor, muscarinic 1 |
to-be-curated |
1 |
| cholinergic receptor, muscarinic 1 |
to-be-curated |
23 |
| cholinergic receptor, muscarinic 2 [Homo sapiens] |
to-be-curated |
1 |
| cholinergic receptor, muscarinic 4 |
to-be-curated |
51 |
| Cholinergic, muscarinic |
to-be-curated |
230 |
| Cholinergic, Nicotinic Alpha1Beta1DeltaGamma |
to-be-curated |
5 |
| Cholinergic, Nicotinic Alpha2Beta4 |
to-be-curated |
7 |
| Cholinergic, Nicotinic Alpha3Beta4x |
to-be-curated |
18 |
| Cholinergic, Nicotinic Alpha4Beta2 |
to-be-curated |
55 |
| Cholinergic, Nicotinic Alpha4Beta4 |
to-be-curated |
8 |
| Cholinergic, Nicotinic Alpha7 |
to-be-curated |
5 |
| CHRM1 |
to-be-curated |
171 |
| CHRM2 |
to-be-curated |
198 |
| CHRM3 |
to-be-curated |
138 |
| CHRM4 |
to-be-curated |
203 |
| CHRM5 |
to-be-curated |
76 |
| Chymase |
Chymase/Chymotrypsin Chromogenic Substrate |
2 |
| Chymotrypsin |
Chymase/Chymotrypsin Chromogenic Substrate |
2 |
| Suc-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin |
27 |
| cIAP-1 BIR3 |
AVP-diPhe-FAM |
5 |
| Smac-derived peptide |
5 |
| cIAP-2 BIR3 |
AVP-diPhe-FAM |
5 |
| Smac-derived peptide |
5 |
| cIAP1-BIR3 |
AVP-diPhe-FAM |
5 |
| cIAP2-BIR3 |
AVP-diPhe-FAM |
3 |
| CIT |
to-be-curated |
20 |
| citrate synthase 2 |
to-be-curated |
26 |
| CLK1 |
biotinylated affinity ligand |
16 |
| CLK2 |
to-be-curated |
13 |
| CLK3 |
to-be-curated |
4 |
| CLK4 |
biotinylated affinity ligand |
13 |
| CNR1 |
to-be-curated |
83 |
| CNR2 |
to-be-curated |
2 |
| coagulation factor XI |
to-be-curated |
94 |
| Coagulation factor XII precursor (Hageman factor) (HAF) |
to-be-curated |
742 |
| Collagenase (ChC) |
Collagenase Substrate |
187 |
| complement component 1, s subcomponent |
to-be-curated |
205 |
| core protein |
to-be-curated |
92 |
| Corticotropin-releasing Factor Receptor 1 |
125I-Tyr(0)-ovine-CRF |
135 |
| COX-1 |
to-be-curated |
24 |
| COX-2 |
to-be-curated |
25 |
| CRF2 Beta |
to-be-curated |
4 |
| CRHR1 |
to-be-curated |
7 |
| CSK |
to-be-curated |
9 |
| CSNK1A1L |
to-be-curated |
4 |
| CSNK1D |
to-be-curated |
11 |
| CSNK1E |
to-be-curated |
14 |
| CSNK1G1 |
to-be-curated |
3 |
| CSNK1G2 |
to-be-curated |
5 |
| CSNK1G3 |
to-be-curated |
5 |
| CSNK2A1 |
to-be-curated |
7 |
| CSNK2A2 |
to-be-curated |
7 |
| cyclin B1 |
to-be-curated |
38 |
| Cyclin-Dependent Kinase 1 (CDK1) |
biotinylated CDK peptide substrate |
3 |
| Biotinylated CDK1 Peptide Substrate |
99 |
| Biotinylated peptide substrate |
4 |
| GST-Rb fusion protein |
85 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
652 |
| Not Available |
1 |
| Peptide Substrate |
102 |
| Rb (Ser780) Biotinylated Peptide |
4 |
| S1 peptide |
5 |
| Substrate Peptide SerThr 18 |
3 |
| Cyclin-Dependent Kinase 2 (CDK2) |
biotinylated CDK peptide substrate |
3 |
| Biotinylated peptide substrate |
76 |
| CDK2 biotinylated peptide substrate |
4 |
| CDK2 Peptide Subsrate |
22 |
| CDKtide |
3 |
| GST-Rb fusion protein |
675 |
| Histidine-tagged Rb |
68 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
548 |
| Histone type 3 |
20 |
| ING Peptide |
144 |
| Not Available |
1 |
| Peptide Substrate |
132 |
| Rb(21) |
8 |
| S1 peptide |
13 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H) |
Histone H1 |
1 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H/L83V/H84D) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (F82H/L83V/H84D/K89T) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (K89T) |
Histone H1 |
2 |
| Cyclin-Dependent Kinase 2 (CDK2) Mutant (L83V/H84D) |
Histone H1 |
1 |
| Cyclin-Dependent Kinase 4 (CDK4) |
Biotinylated Peptide Substrate |
30 |
| G1 peptide |
43 |
| GST-Rb fusion protein |
665 |
| Histidine-tagged retinoblastoma protein |
26 |
| Histone H1 |
9 |
| ING Peptide |
160 |
| Rb |
2 |
| Rb(21) |
95 |
| Retinoblastoma (Rb) |
13 |
| Cyclin-Dependent Kinase 5 (CDK5) |
Cdk5 Substrate |
1 |
| Histone H1 |
301 |
| Histone H1 Peptide |
1 |
| Cyclin-Dependent Kinase 6 (CDK6) |
G1 peptide |
1 |
| Histone H1 |
7 |
| cyclin-dependent kinase 7 |
to-be-curated |
18 |
| Cyclin-Dependent Kinase 7 (CDK7) |
biotinylated affinity ligand |
12 |
| Biotinylated Peptide Substrate |
7 |
| FAM-CDK7 derived peptide |
18 |
| Histone H1 |
4 |
| Cyclin-Dependent Kinase 8 (CDK8) |
biotinylated affinity ligand |
8 |
| Cyclin-Dependent Kinase 9 (CDK9) |
biotinylated affinity ligand |
6 |
| Biotinylated Peptide Substrate |
7 |
| pRB |
4 |
| RNA Polymerase CTD Peptide |
2 |
| Cyclooxygenase-1 |
Arachidonic acid |
33 |
| [1-14C]Arachidonic acid |
39 |
| Cyclooxygenase-2 |
Arachidonic acid |
30 |
| [1-14C]Arachidonic acid |
45 |
| cysteine protease ATG4B isoform a |
to-be-curated |
334 |
| Cytochrome b-245, beta polypeptide [Homo sapiens] |
to-be-curated |
4 |
| Cytochrome P450 1A2 |
Ethoxyresorufin |
1 |
| Cytochrome P450 2A6 |
Coumarin |
31 |
| Cytochrome P450 2C19 |
3-butyryl-7- methoxycoumarin |
7 |
| S-Mephenytoin |
1 |
| Cytochrome P450 2C9 |
7-methoxy-4-trifluoromethylcoumarin-3-acetic acid |
7 |
| Diclofenac |
1 |
| MFC |
21 |
| Cytochrome P450 2D6 |
4-Methylaminomethyl-7-methoxycoumarin |
7 |
| Bufuralol |
1 |
| Cytochrome P450 2E1 |
p-nitrophenol |
9 |
| Cytochrome P450 3A1 |
erythromycin |
11 |
| Cytochrome P450 3A4 |
7-Benzyloxyquinoline |
7 |
| BFC |
31 |
| Midazolam |
1 |
| Testosterone |
52 |
| Cytochrome P450 51(CYP51) |
Not Available |
26 |
| Cytochrome P450 51(CYP51) Mutant (F78L) |
Not Available |
2 |
| D-Amino Acid Oxidase (DAAO) |
D-Serine |
61 |
| Not Available |
7 |
| D-Aspartate Oxidase (DDO) |
D-Aspartic Acid |
23 |
| DAPK1 |
to-be-curated |
6 |
| DAPK2 |
to-be-curated |
5 |
| DAPK3 |
to-be-curated |
7 |
| DCAMKL1 |
to-be-curated |
6 |
| DCAMKL2 |
to-be-curated |
4 |
| DCAMKL3 |
to-be-curated |
10 |
| defective in Germ Line Development family member (gld-1) |
to-be-curated |
77 |
| Delta Opioid Receptor |
[3H]-diprenorphine |
69 |
| [3H]-naltrindole |
21 |
| [3H]DPDPE |
53 |
| delta-type opioid receptor |
to-be-curated |
229 |
| Dengue Virus 1 (DENV1) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 2 (DENV2) NS2B-NS3 Protease |
Boc-Gly-Arg-Arg-AMC |
5 |
| Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 3 (DENV3) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Dengue Virus 4 (DENV4) NS2B-NS3 Protease |
Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| Diacyl Glycerolacyltransferase 1 (DGAT-1) |
didecanoyl glycerol |
25 |
| [14C] oleoyl coenzyme A |
9 |
| Diacyl Glycerolacyltransferase 2 (DGAT-2) |
[14C] oleoyl coenzyme A |
2 |
| Dihydrofolate Reductase (DHFR) |
dihydrofolic acid |
612 |
| Dihydrofolate Reductase (DHFR) Mutant (F98Y) |
dihydrofolic acid |
2 |
| Dihydrofolate Reductase (DHFR) Mutant (I100L) |
dihydrofolic acid |
2 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) |
dihydrofolic acid |
22 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant KICB1 |
dihydrofolic acid |
3 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant SP21 |
dihydrofolic acid |
19 |
| Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) Mutant V1/S |
dihydrofolic acid |
3 |
| Dihydroorotate Dehydrogenase (DHODH) |
Coenzyme Q1 |
9 |
| Coenzyme Q6 |
18 |
| Decylubiquinone |
181 |
| Ubiquinone-0 (CoQ0) |
40 |
| Dihydroorotate Dehydrogenase (DHODH) Mutant (H185A) |
Ubiquinone-0 (CoQ0) |
13 |
| Dihydroorotate Dehydrogenase (DHODH) Mutant (R265A) |
Ubiquinone-0 (CoQ0) |
13 |
| Dipeptidyl Peptidase II (DPP-II) (QPP) |
Nle-Pro-AMC |
52 |
| Dipeptidyl Peptidase IV (DPP-IV) |
Ala-Pro-7-amido-4-trifluoromethylcoumarin |
48 |
| Gly-Pro-AMC |
501 |
| Gly-Pro-pNA |
149 |
| H-Ala-Pro-pNA |
49 |
| Dipeptidyl Peptidase VII (DPP-VII) (QPP) |
Gly-Pro-pNA |
47 |
| Lys-Ala-pNA |
67 |
| Nle-Pro-AMC |
215 |
| diphosphomevalonate decarboxylase |
to-be-curated |
348 |
| DLK |
to-be-curated |
8 |
| DMPK |
to-be-curated |
9 |
| DMPK2 |
to-be-curated |
7 |
| DNA damage-inducible transcript 3 protein |
to-be-curated |
1880 |
| DNA dC->dU-editing enzyme APOBEC-3G |
to-be-curated |
907 |
| DNA Gyrase |
ATP |
44 |
| Kinetoplast DNA |
5 |
| DNA Ligase (MtuLigA) |
32P-labeled nicked duplex DNA substrate |
7 |
| DNA Ligase I |
32P-labeled nicked duplex DNA substrate |
4 |
| DNA Polymerase alpha |
dGTP |
2 |
| DNA template-primer |
10 |
| DNA Polymerase beta |
DNA template-primer |
10 |
| DNA Polymerase gamma |
dGTP |
2 |
| DNA polymerase III subunit gamma |
2'-deoxyadenosine triphosphate |
13 |
| DNA polymerase IIIC |
dGTP |
2 |
| DNA polymerase IIIE |
dGTP |
4 |
| DNA recombination protein RecA |
to-be-curated |
711 |
| DNA Topoisomerase IV |
ATP |
22 |
| Kinetoplast DNA |
5 |
| Dopamine D1 high |
to-be-curated |
14 |
| Dopamine D1 low |
to-be-curated |
14 |
| dopamine D1 receptor; DA D1 receptor |
to-be-curated |
226 |
| Dopamine D1A |
to-be-curated |
13 |
| Dopamine D1B |
to-be-curated |
14 |
| Dopamine D2A |
to-be-curated |
5 |
| DOPAMINE D4.2 |
to-be-curated |
61 |
| DOPAMINE D4.4 |
to-be-curated |
30 |
| Dopamine Receptor D2 |
[3H]-Spiroperidol |
39 |
| Dopamine receptor D3 [Homo sapiens] |
to-be-curated |
1 |
| dopamine receptor D5 |
to-be-curated |
100 |
| Dopamine Transporter (DAT) |
[125I]RTI-55 |
64 |
| [3H]WIN 35,428 |
19 |
| Dopamine2-like |
to-be-curated |
63 |
| DPP8 |
Ala-Pro-7-amido-4-trifluoromethylcoumarin |
297 |
| Gly-Pro-AMC |
38 |
| Gly-Pro-pNA |
65 |
| DPP9 |
Gly-Pro-AMC |
275 |
| DRAK1 |
to-be-curated |
10 |
| DRAK2 |
to-be-curated |
9 |
| DRD1 |
to-be-curated |
420 |
| DRD2 |
to-be-curated |
1184 |
| DRD3 |
to-be-curated |
265 |
| DRD4 |
to-be-curated |
189 |
| DRD5 |
to-be-curated |
41 |
| drug resistance protein 1 |
to-be-curated |
28 |
| drug resistance protein 2 |
to-be-curated |
33 |
| dTDP-4-dehydrorhamnose 3,5-epimerase RmlC |
to-be-curated |
387 |
| dual specificity phosphatase 1 |
to-be-curated |
209 |
| dual specificity phosphatase 3 |
to-be-curated |
397 |
| dual specificity phosphatase 6 |
to-be-curated |
416 |
| Dual Specificity Protein Phosphatase 1 |
OMFP Substrate |
165 |
| DYRK1A |
myelin basic protein |
3 |
| DYRK1B |
to-be-curated |
8 |
| EBNA-1 protein |
to-be-curated |
127 |
| EDNRA |
to-be-curated |
8 |
| EDNRB |
to-be-curated |
10 |
| EGF |
to-be-curated |
2 |
| EGF-R Tyrosine Kinase |
(Biotin)Poly(Glu:Tyr) |
4 |
| Angiotensin II |
30 |
| Biotinylated EGFR Peptide Substrate |
19 |
| biotinylated gastrin substrate |
1 |
| Biotinylated Peptide Substrate |
41 |
| EGF Receptor Substrate |
23 |
| EGF-R Substrate |
325 |
| EGFR Substrate |
174 |
| EGFR Substrate Peptide |
22 |
| N-biotinyl peptide substrate |
1 |
| Not Available |
19 |
| poly(E, A, Y) |
93 |
| poly(E,A,Y) |
30 |
| poly(E,Y) |
13 |
| Poly(E:A:Y) |
3 |
| Poly(E:Y) |
41 |
| Poly(GAT) |
170 |
| poly(Glu4-Tyr) |
13 |
| poly(Glu4/Tyr) |
24 |
| Tyr 04 Substrate Peptide |
4 |
| EGF-R Tyrosine Kinase Mutant (G719C) |
biotinylated affinity ligand |
20 |
| EGF-R Tyrosine Kinase Mutant (G719S) |
Not Available |
2 |
| EGF-R Tyrosine Kinase Mutant (L858R) |
Not Available |
4 |
| EGF-R Tyrosine Kinase Mutant (L858R/T790M) |
Not Available |
2 |
| EGF-R Tyrosine Kinase Mutant (T790M) |
Not Available |
2 |
| Tyr 04 Substrate Peptide |
4 |
| EGFR |
to-be-curated |
17 |
| EGFR(E746-A750del) |
to-be-curated |
14 |
| EGFR(G719S) |
to-be-curated |
17 |
| EGFR(L747-E749del A750P) |
to-be-curated |
19 |
| EGFR(L747-S752del P753S) |
to-be-curated |
17 |
| EGFR(L747-T751del Sins) |
to-be-curated |
17 |
| EGFR(L858R) |
to-be-curated |
16 |
| EGFR(L861Q) |
to-be-curated |
16 |
| EGFR(S752-I759del) |
to-be-curated |
15 |
| electroneutral potassium-chloride cotransporter KCC2 |
to-be-curated |
992 |
| endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 |
to-be-curated |
1524 |
| endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 |
to-be-curated |
360 |
| endothelial differentiation, sphingolipid G-protein-coupled receptor, 5 |
to-be-curated |
345 |
| ENDOTHELIN |
to-be-curated |
1 |
| Endothelin-Converting Enzyme 1 |
Pya(21)-(p-NO2)Phe(22)bigET(19-35) |
29 |
| Enoyl-ACP Reductase (FabI) |
Crotonoyl-ACP |
50 |
| Crotonoyl-CoA |
111 |
| Enoyl-ACP Reductase (FabK) |
Crotonoyl-ACP |
5 |
| Enoyl-ACP Reductase (InhA) |
2-trans-Octenoyl-CoA (OCoA) |
100 |
| trans-2-Dodecenoyl-Coenzyme A |
13 |
| Enoyl-ACP Reductase (PfENR) |
Crotonoyl-CoA |
28 |
| envelope glycoprotein |
to-be-curated |
83 |
| Eph receptor A4 |
to-be-curated |
268 |
| EPHA1 |
to-be-curated |
9 |
| EPHA2 |
to-be-curated |
10 |
| EPHA4 |
to-be-curated |
9 |
| EPHA5 |
to-be-curated |
7 |
| EPHA8 |
to-be-curated |
13 |
| EPHB1 |
to-be-curated |
9 |
| EPHB2 |
to-be-curated |
7 |
| Ephrin type-B receptor 4 precursor (Tyrosine-protein kinase receptor HTK). |
to-be-curated |
128 |
| epoxide hydrolase 2, cytoplasmic |
to-be-curated |
54 |
| Epoxide Hydrolase B (EHB) |
alpha-cyanocarbonate epoxide |
20 |
| Equilibrative Nucleoside Transporter 1 (ENT1) |
5-(SAENTA)-X8-fluorescein |
80 |
| ErbB-2 (HER2) Tyrosine Kinase |
Biotinylated ErbB-2 Peptide Substrate |
19 |
| Biotinylated Peptide Substrate |
41 |
| ErbB-2 Substrate Peptide |
22 |
| HER-2 Substrate |
38 |
| poly(Glu4/Tyr) |
24 |
| ErbB-4 (HER4) Tyrosine Kinase |
Biotinylated ErbB-4 Peptide Substrate |
9 |
| ERBB2 |
to-be-curated |
8 |
| ERBB4 |
to-be-curated |
10 |
| ERK-2 |
biotin-MBP protein |
1 |
| EGFR Peptide Substrate |
2 |
| ERK-2 Peptide Substrate |
4 |
| erktide |
24 |
| Histone H1 |
3 |
| Substrate Peptide T669 |
5 |
| ERK-8 |
biotinylated affinity ligand |
9 |
| ERK1 |
to-be-curated |
1 |
| ERK2 |
to-be-curated |
1 |
| ERK3 |
to-be-curated |
5 |
| ERK4 |
to-be-curated |
4 |
| ERK5 |
to-be-curated |
4 |
| Estrogen Receptor (ER-alpha) |
17beta-estradiol (E2) |
134 |
| Estrone (E1) |
56 |
| [3H]-estradiol |
25 |
| [3H]]estradiol |
15 |
| Estrogen Receptor (ER-beta) |
17beta-estradiol (E2) |
134 |
| Estrone (E1) |
56 |
| Estrogen receptor 1 |
to-be-curated |
556 |
| estrogen receptor alpha |
to-be-curated |
27 |
| Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2). |
to-be-curated |
30 |
| estrogen receptor beta isoform 1 |
to-be-curated |
728 |
| Estrogen-Related Receptor, alpha |
PGC-1 alpha derived peptide |
2 |
| Estrogen-Related Receptor, gamma |
Biotinylated RIP140 peptide |
12 |
| [3H]4-OHT |
19 |
| eukaryotic translation initiation factor 2-alpha kinase 3 |
to-be-curated |
236 |
| eukaryotic translation initiation factor 4 gamma, 1 isoform 4 |
to-be-curated |
535 |
| Eukaryotic translation initiation factor 4H |
to-be-curated |
242 |
| exonuclease V (RecBCD complex), alpha chain |
to-be-curated |
225 |
| Factor IXa (fIXa) |
Chromogenic Substrate |
7 |
| Factor IX Chromogenic Substrate |
85 |
| Factor VIIa (fVIIa) |
Chromogenic Substrate |
7 |
| Chromozym tPA |
66 |
| Factor VII Chromogenic Substrate |
108 |
| Not Specified |
3 |
| Pefachrome FVIIa |
96 |
| Spectrozyme-FVIIa |
46 |
| Factor Xa (fXa) |
Chromogenic Substrate Pefachrome FXa |
63 |
| Chromogenic Substrate S-2222 |
461 |
| Chromogenic Substrate S-2765 |
472 |
| Chromogenic Substrate Spectrozyme FXa |
37 |
| Chromozym X |
39 |
| Factor Xa (fXa) Chromogenic Substrate |
57 |
| Factor Xa Chromogenic Substrate |
7 |
| Factor Xa Fluorogenic Substrate |
24 |
| MeSO2-D-Nle-Gly-Arg-pNA |
54 |
| Not Specified |
3 |
| rhodamime 110, bis-(Boc-L-glycylglycyl-L-arginine amide) |
25 |
| Factor XIa (fXIa) |
Boc-Glu-Ala-Arg-AMC |
396 |
| Fluorogenic Tripeptide Substrate |
31 |
| Not Specified |
3 |
| Factor XIIa (fXIIa) |
Boc-Gln-Gly-Arg-AMC |
87 |
| Chromogenic Substrate S-2302 |
36 |
| Falcipain-2 |
Z-Leu-Arg-AMC |
30 |
| Farnesoid X-Activated Receptor |
biotin-tagged SRC-1 |
4 |
| Biotinylated SRC-1 Peptide |
5 |
| Not Available |
54 |
| Farnesyl pyrophosphate synthase (FPPS) |
DMAPP |
12 |
| Fatty Acid Amide Hydrolase |
14C-labeled oleamide |
115 |
| FP-rhodamine |
1 |
| Oleamide |
18 |
| [14C]Anandamide |
39 |
| [3H]Anandamide |
82 |
| Fatty Acid Synthase |
4-methylumbelliferyl heptanoate (4-MUH) |
46 |
| FER |
to-be-curated |
8 |
| FES |
to-be-curated |
4 |
| FGFR-1 Tyrosine Kinase |
Biotinylated FGFR Peptide Substrate |
2 |
| biotinylated gastrin substrate |
1 |
| N-biotinyl peptide substrate |
1 |
| Poly (E:Y) |
1 |
| poly(E,A,Y) |
67 |
| Poly(E:Y) |
396 |
| Substrate Peptide Tyr 04 |
1 |
| FGFR-1, (FL) |
to-be-curated |
1 |
| FGFR-2 Tyrosine Kinase |
(Biotin)Poly(Glu:Tyr) |
3 |
| FGFR Substrate |
7 |
| FGFR1 |
to-be-curated |
16 |
| FGFR2 |
to-be-curated |
13 |
| FGFR3 |
to-be-curated |
10 |
| FGFR3(G697C) |
to-be-curated |
10 |
| FGFR4 |
to-be-curated |
6 |
| FGR |
to-be-curated |
18 |
| Fibroblast Activation Protein (FAP) |
Gly-Pro-pNA |
18 |
| Focal adhesion kinase 1 (FADK 1) (pp125FAK) (Protein-tyrosine kinase 2). |
to-be-curated |
210 |
| formyl peptide receptor 1 |
to-be-curated |
656 |
| Formyl Peptide Receptor-Like 1 |
Not Available |
18 |
| formyl peptide receptor-like 1 |
to-be-curated |
690 |
| FXN frataxin |
to-be-curated |
241 |
| FYN |
to-be-curated |
16 |
| G protein signalling regulator 19 |
to-be-curated |
228 |
| G protein-activated inward rectifier potassium channel 1 |
to-be-curated |
9 |
| G protein-coupled receptor 35 |
to-be-curated |
436 |
| G protein-coupled receptor 55 |
to-be-curated |
629 |
| G-protein Coupled Receptor 40 |
Not Available |
52 |
| G-protein Coupled Receptor 54 |
[125I]Kisspeptin-15 |
12 |
| GABA |
to-be-curated |
64 |
| GABA A |
to-be-curated |
49 |
| GABA A Alpha1Beta1Gamma2 |
to-be-curated |
24 |
| GABA A Alpha1Beta2Gamma2 |
to-be-curated |
11 |
| GABA A Alpha1Beta3Gamma2 |
to-be-curated |
35 |
| GABA A Alpha2Beta1Gamma2 |
to-be-curated |
18 |
| GABA A Alpha2Beta3Gamma2 |
to-be-curated |
9 |
| GABA A Alpha3Beta1Gamma2 |
to-be-curated |
18 |
| GABA A Alpha3Beta3Gamma2 |
to-be-curated |
9 |
| GABA A Alpha4Beta2Gamma2 |
to-be-curated |
25 |
| GABA A Alpha4Beta3Gamma2 |
to-be-curated |
15 |
| GABA A Alpha4Gamma2 |
to-be-curated |
5 |
| GABA A Alpha5Beta1Gamma2 |
to-be-curated |
9 |
| GABA A Alpha5Beta2Gamma2 |
to-be-curated |
3 |
| GABA A Alpha5Beta3Gamma2 |
to-be-curated |
12 |
| GABA A Alpha5m10Beta2Gamma2 |
to-be-curated |
4 |
| GABA A Alpha5m8Beta2Gamma2 |
to-be-curated |
3 |
| GABA A Alpha5m9Beta2Gamma2 |
to-be-curated |
2 |
| GABA A Alpha6Beta2Gamma2 |
to-be-curated |
27 |
| GABA A Alpha6Beta3Gamma2 |
to-be-curated |
19 |
| GABA A anti-Alpha1 |
to-be-curated |
4 |
| GABA A anti-Alpha3 |
to-be-curated |
4 |
| GABA A Benzodiazepine |
to-be-curated |
133 |
| GABA A Benzodiazepine brain |
to-be-curated |
1 |
| GABA A Benzodiazepine liver |
to-be-curated |
1 |
| GABA A Benzodiazepine omega1 |
to-be-curated |
3 |
| GABA A Benzodiazepine omega2 |
to-be-curated |
3 |
| GABA A Benzodiazepine omega5 |
to-be-curated |
3 |
| GABA B |
to-be-curated |
16 |
| GABA C |
to-be-curated |
7 |
| GABA uptake |
to-be-curated |
4 |
| GABA-PICROTOXIN |
to-be-curated |
1 |
| GABAA Receptor Mutant, alpha-1 (A160C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (D97C), beta-2, gamma-2 |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1 (F99C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (G157C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (G200C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (S204C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (S205C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (T162C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (T206C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (V202C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (V211C), beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1 (Y209C), beta-2, gamma-2 |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (A79C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (Chimera) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (D56C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (F77C) |
[3H]Ro15-1788 |
1 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (L140C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (M130C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R132C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R144C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R185C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (R194C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T126C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T142C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor Mutant, alpha-1, beta-2, gamma-2 (T81C) |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-1, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-1, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-2, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-2, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-3, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-3, beta-3, gamma-2 |
[3H]flunitrazepam |
7 |
| GABAA Receptor, alpha-4, beta-2, gamma-2 |
[3H]Ro15-4513 |
3 |
| GABAA Receptor, alpha-4, beta-3, gamma-2 |
[3H]flunitrazepam |
4 |
| GABAA Receptor, alpha-5, beta-2, gamma-2 |
[3H]Ro15-1788 |
3 |
| GABAA Receptor, alpha-5, beta-3, gamma-2 |
[3H]flunitrazepam |
8 |
| GABAA Receptor, alpha-6, beta-2, gamma-2 |
[3H]Ro15-4513 |
3 |
| GABAA Receptor, alpha-6, beta-3, gamma-2 |
[3H]flunitrazepam |
7 |
| GAK |
to-be-curated |
21 |
| GALANIN |
to-be-curated |
5 |
| Galanin receptor type 2 (GAL2-R) (GALR2). |
to-be-curated |
116 |
| Galectin-1 |
fluorescein-tagged saccharide |
14 |
| Galectin-3 |
fluorescein-tagged saccharide |
23 |
| Galectin-7 |
fluorescein-tagged saccharide |
12 |
| Galectin-8 |
fluorescein-tagged saccharide |
11 |
| Galectin-9 |
fluorescein-tagged saccharide |
12 |
| GALR1 |
to-be-curated |
53 |
| GALR2 |
to-be-curated |
62 |
| GALR3 |
to-be-curated |
49 |
| gamma-Aminobutyric Acid Type B Receptor |
[3H]GABA |
16 |
| Gamma-Secretase |
beta-Amyloid Precursor Protein (APP) |
98 |
| GAR Tfase |
GAR |
18 |
| Gastric Inhibitory Polypeptide Receptor (GIPR) |
125I-GIP |
30 |
| GCN2(Kin.Dom.2 S808G) |
to-be-curated |
12 |
| Geranylgeranyl Diphosphate Synthase (GGPPS) |
[14C]IPP |
61 |
| Geranylgeranyl Transferase (GGTase-I) |
Biotinylated Peptide Substrate |
29 |
| Ha-Ras-CVLL |
28 |
| K-ras(B) decapeptide |
43 |
| PGGT I peptide substrate |
1 |
| Ras-CVLL |
1 |
| Ghrelin Receptor (Growth Hormone Secretagogue Receptor Type 1) |
125I-His9-ghrelin |
118 |
| Not Available |
13 |
| Glucagon Receptor |
125I-Glucagon |
30 |
| Glucocerebrosidase (Acid beta-Glucosidase) |
4-methylumbelliferyl beta-D-glucoside |
18 |
| resorufin-beta-D-glucopyranoside |
59 |
| Glucocerebrosidase (GBA) |
4-Methylumbelliferyl B-D-glucopyranoside |
5 |
| Glucocorticoid Receptor (GR) |
dexamethasone |
84 |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
49 |
| Glucokinase |
D-glucose |
34 |
| glucose-6-phosphate 1-dehydrogenase isoform b |
to-be-curated |
304 |
| glucose-6-phosphate dehydrogenase |
to-be-curated |
168 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase |
to-be-curated |
912 |
| Glucosylceramidase precursor (Beta-glucocerebrosidase) (Acid beta-glucosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) (Alglucerase) (Imiglucerase). |
to-be-curated |
158 |
| Glutamate Carboxypeptidase II (GCPII) |
N-acetylaspartylglutamate (NAAG) |
42 |
| Glutamate kainate |
to-be-curated |
31 |
| glutamate receptor, metabotropic 2 precursor |
to-be-curated |
2 |
| glutamate receptor, metabotropic 3 precursor |
to-be-curated |
2 |
| Glutamate receptor, metabotropic 4 |
to-be-curated |
33 |
| glutamate receptor, metabotropic 4 precursor |
to-be-curated |
33 |
| glutamate receptor, metabotropic 5 |
to-be-curated |
2 |
| glutamate receptor, metabotropic 6 precursor |
to-be-curated |
1 |
| glutamate receptor, metabotropic 8 precursor |
to-be-curated |
2 |
| Glutamate-NMDA |
to-be-curated |
97 |
| Glutamate-NMDA-Channel |
to-be-curated |
3 |
| Glutamate-NMDA-MK801 |
to-be-curated |
98 |
| Glutamate-NMDA-Polyamine |
to-be-curated |
3 |
| Glutaminyl Cyclase |
Gln-AMC |
90 |
| glutathione S-transferase |
to-be-curated |
235 |
| glutathione S-transferase omega-1 isoform 1 |
to-be-curated |
2 |
| glyceraldehyde-3-phosphate dehydrogenase |
to-be-curated |
33 |
| Glycine |
to-be-curated |
12 |
| Glycine, non-strychnine |
to-be-curated |
4 |
| Glycine, strychnine |
to-be-curated |
5 |
| Glycogen Phosphorylase (PYGL) |
glycogen |
102 |
| Glycogen Phosphorylase (PYGM) |
glucose-1-phosphate |
73 |
| glycogen synthase kinase 3 beta isoform 1 |
to-be-curated |
2198 |
| Glycogen Synthase Kinase-3, alpha |
Biotinylated Peptide Substrate |
171 |
| GSK-3 Peptide Substrate |
2 |
| Glycogen Synthase Kinase-3, beta |
Biotinylated peptide substrate |
90 |
| GS-1 Peptide |
31 |
| GSK-3 beta Substrate Peptide |
30 |
| GSK-3 Peptide Substrate |
29 |
| GSK-3 Substrate Peptide |
24 |
| Phospho-GS2 Substrate Peptide |
1 |
| Phosphor-Glycogen Synthase Peptide-2 |
3 |
| GPR7 |
to-be-curated |
11 |
| GRB2 |
Grb2 SH2 Binding Substrate |
15 |
| GRIA3 |
to-be-curated |
90 |
| GRIK4 |
to-be-curated |
9 |
| GRM2 |
to-be-curated |
67 |
| GRM3 |
to-be-curated |
8 |
| GRM4 |
to-be-curated |
20 |
| GRM6 |
to-be-curated |
6 |
| GRM7 |
to-be-curated |
3 |
| GRM8 |
to-be-curated |
2 |
| GSK3A |
to-be-curated |
5 |
| GSK3B |
to-be-curated |
9 |
| GTP-binding protein (rab7) |
to-be-curated |
223 |
| guanine nucleotide-binding protein G(o) subunit alpha isoform a |
to-be-curated |
20 |
| HCK |
to-be-curated |
15 |
| HCV NS3 Helicase |
DNA Substrate |
12 |
| HCV NS3-NS4A Serine Proteinase |
NS3-NS4A Chromogenic Peptide Substrate |
291 |
| NS4B-5A |
30 |
| HCV NS5B Polymerase |
biotinylated oligo (rG13)/poly rC |
165 |
| poly(A)/oligo(U)18 |
43 |
| HCV NS5B Polymerase Mutant (M414T) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (M423K) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (P495A) |
poly(A)/oligo(U)18 |
2 |
| HCV NS5B Polymerase Mutant (R501E) |
poly(A)/oligo(U)18 |
2 |
| Heat Shock 70kDa Protein 1 |
Fluorescein-12-ATP |
33 |
| N6-(6-amino)hexyl-ATP-5-FAM |
17 |
| Not Available |
8 |
| heat shock 70kDa protein 1A |
to-be-curated |
64 |
| heat shock 70kDa protein 8 isoform 1 |
to-be-curated |
32 |
| heat shock 70kDa protein 8 isoform 2 |
to-be-curated |
21 |
| heat shock protein 90 |
to-be-curated |
244 |
| Heat Shock Protein 90 (Hsp90) |
ATP |
14 |
| BODIPY-labeled Geldanamycin |
9 |
| cy3B-GM |
268 |
| Not Available |
81 |
| VER-00045864 |
25 |
| VER-00051001 |
100 |
| heat shock protein 90kDa alpha (cytosolic), class A member 1 isoform 2 |
to-be-curated |
81 |
| Heme Oxygenase 1 (HO-1) |
methemalbumin |
44 |
| Heme Oxygenase 2 (HO-2) |
methemalbumin |
44 |
| Hepsin |
Hepsin Chromogenic Substrate |
6 |
| hERG Potassium Channel 1 |
Not Available |
10 |
| [35S]-MK499 |
53 |
| [3H]Astemizole |
21 |
| hexokinase |
to-be-curated |
190 |
| hexokinase-1 isoform HKI |
to-be-curated |
101 |
| Histamine H1 Receptor |
[3H]Chlorpheniramine |
18 |
| [3H]mepyramine |
5 |
| [3H]pyrilamine |
3 |
| Histamine H2 Receptor |
tiotidine |
1 |
| [3H]tiotidine |
5 |
| Histamine H3 Receptor |
[3H]N-alpha-methyl histamine |
104 |
| Histamine H4 Receptor |
[3H]histamine |
119 |
| Histone Deacetylase (pfHDAC-1) |
pfHDAC-1 Substrate |
23 |
| Histone Deacetylase 1 (HDAC1) |
Ac-KGLGK(Ac)-AMC |
14 |
| acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
5 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
18 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor de Lys-H4-AcK16 |
25 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
100 |
| Fluorophore-conjugated substrate |
3 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 10 (HDAC10) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
17 |
| Histone Deacetylase 11 (HDAC11) |
Boc-Ac-Lys-AMC |
1 |
| Histone Deacetylase 2 (HDAC2) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
18 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
5 |
| Histone Deacetylase 3 (HDAC3) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
7 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
17 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
62 |
| Histone Deacetylase 4 (HDAC4) |
Ac-KGLGK(Ac)-AMC |
8 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
48 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 4 (HDAC4) Mutant (H976Y) |
Fluor-de-Lys Fluorogenic Deacetylase Substrate |
48 |
| Histone Deacetylase 5 (HDAC5) |
Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
5 |
| Histone Deacetylase 6 (HDAC6) |
Ac-KGLGK(Ac)-AMC |
14 |
| acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor-de-Lys Fluorogenic Deacetylase Substrate |
47 |
| Fluorophore-conjugated substrate |
3 |
| [3H]acetyl-labeled histones |
19 |
| Histone Deacetylase 7 (HDAC7) |
Boc-Ac-Lys-AMC |
1 |
| Boc-L-Lys-MCA |
5 |
| Histone Deacetylase 8 (HDAC8) |
acetyl-Gly-Ala-(N-acetyl-Lys)-AMC |
1 |
| Boc-Ac-Lys-AMC |
1 |
| Boc-Lys (Ac) -AMC |
7 |
| Carboxyfluorescein (FAM)-labeled acetylated peptide |
18 |
| Fluor de Lys-HDAC8 Fluorogenic Deacetylase Substrate |
22 |
| Fluorophore-conjugated substrate |
3 |
| Histone Lysine Demethylase |
Histone H3 fragment substrate |
19 |
| Histone-Arginine Methyltransferase CARM1 |
Histone H3 |
19 |
| HIV-1 Integrase |
Biotinylated Target DNA |
144 |
| DIG-tagged Target DNA |
13 |
| [3H]Target DNA |
88 |
| HIV-1 Protease |
Biotinylated HIV-1 Protease Peptide Substrate |
84 |
| Chromogenic peptide substrate |
5 |
| Chromogenic Peptide Substrate |
71 |
| Chromogenic Substrate |
3 |
| decapeptide substrate |
46 |
| fluorescence peptide substrate |
1 |
| Fluorescent peptide substrate |
388 |
| Fluorogenic Peptide Substrate |
312 |
| fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| Fluorogenic substrate |
4 |
| Fluorogenic substrate Abz-NF-6* |
11 |
| HIV Peptide Substrate |
2 |
| HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV Protease peptide substrate |
17 |
| HIV Protease substrate |
26 |
| HIV-1 Peptide Substrate |
83 |
| HIV-1 PR Substrate Peptide |
11 |
| HIV-1 Protease Substrate |
62 |
| HIV-1 proteinase peptide substrate |
18 |
| Peptide Substrate |
170 |
| [3H]GW0385 |
16 |
| HIV-1 Protease AE |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE Mutant (V82F) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE-P |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease AE-P Mutant (F82V) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease B Subtype |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease B Subtype Mutant (V82F) |
HIV Protease Chromogenic Peptide Substrate |
7 |
| HIV-1 Protease Mutant (A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (A71V/V82T/I84V) |
Chromogenic peptide substrate |
1 |
| HIV-1 Protease Mutant (D30N) |
Chromogenic peptide substrate |
5 |
| HIV Peptide Substrate |
2 |
| HIV-1 Protease Mutant (D30N/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (D30N/M36I) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (D30N/M36I/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (G73S) |
Chromogenic Substrate |
3 |
| HIV-1 Protease Mutant (I47L) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (I50L) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (I50V) |
Chromogenic Substrate |
3 |
| fluorescence peptide substrate |
1 |
| HIV Peptide Substrate |
2 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (I84V) |
HIV Peptide Substrate |
2 |
| HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L10I,L19Q,K20R,E35D,M36I, ..) |
fluorescence peptide substrate |
1 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (L23I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L23V) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L24I) |
Chromogenic Substrate |
3 |
| HIV-1 Protease Mutant (L76M) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (L90M) |
HIV Peptide Substrate |
2 |
| HIV-1 Protease Mutant (M36I) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (M36I/A71V) |
Chromogenic peptide substrate |
5 |
| HIV-1 Protease Mutant (M46I,L63P,A71V,V82F,I84V) |
fluorescence peptide substrate |
1 |
| [3H]GW0385 |
5 |
| HIV-1 Protease Mutant (V32I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant (V82A) |
HIV Peptide Substrate |
2 |
| HIV Protease Chromogenic Peptide Substrate |
3 |
| HIV-1 Protease Mutant (V82I) |
HIV-1 Protease substrate |
1 |
| HIV-1 Protease Mutant K-60C |
HIV Protease Peptide Substrate |
15 |
| HIV-1 Protease Mutant M1 (L10I, G48V, I54V, L63P, V82A) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant M2 (D30N, L63P, N88D) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant M3 (L10I, L63P, A71V, G73S, I84V, L90M) |
HIV-1 Protease Substrate |
19 |
| HIV-1 Protease Mutant Q-60C |
HIV Protease Peptide Substrate |
11 |
| HIV-1 Protease Mutant V-18C |
HIV Protease Peptide Substrate |
27 |
| HIV-1 Protease Mutant V6 |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46/54/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(46/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(54) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(54/84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant V6(84) |
HIV Protease Chromogenic Peptide Substrate |
4 |
| HIV-1 Protease Mutant, A-1 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Protease Mutant, ANAM-11 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Protease Mutant, NAM-10 |
fluorogenic peptide substrate, SQNY/PIVQ |
4 |
| HIV-1 Reverse Transcriptase |
(poly)rA:(oligo)dT(12-18) |
139 |
| (poly)rC:(oligo)dG |
224 |
| (rC)n.(dG)12-18 |
149 |
| poly r(A).oligo d(T)16 |
10 |
| poly rC/biotin-dG15 |
36 |
| poly(A)/oligo(dT) |
26 |
| Poly(C)-oligo(dG) |
7 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA)-oligo(dT)(12-18) |
11 |
| poly(rA).oligo(dT)12-18 |
28 |
| poly(rA)/oligo(dT) |
14 |
| poly(rA)600:oligo(dT)10 |
45 |
| poly(rA):oligo(dT) template:primer |
11 |
| poly(rA):oligo(dT)(12-18) |
33 |
| poly(rC)-oligo(dG) |
13 |
| poly(rC)-oligo(dG)(12-18) |
183 |
| poly(rC)500:oligo(dG)10 |
103 |
| Poly(rC):oligo(dG )Template:Primer |
50 |
| poly(rC):oligo(dG) |
313 |
| RNA template(1080) : deoxy-oligo primer(18) |
83 |
| RNA:Biotin-DNA template:primer |
10 |
| RNA:DNA template:primer |
70 |
| HIV-1 Reverse Transcriptase Mutant (103N/181C) |
poly rC/biotin-dG15 |
26 |
| RNA:Biotin-DNA template:primer |
10 |
| HIV-1 Reverse Transcriptase Mutant (G190A) |
poly(rC)500:oligo(dG)10 |
9 |
| HIV-1 Reverse Transcriptase Mutant (K103N) |
(poly)rC:(oligo)dG |
8 |
| (rC)n.(dG)12-18 |
22 |
| poly r(A).oligo d(T)16 |
5 |
| poly(rA)/oligo(dT) |
5 |
| poly(rC)-oligo(dG)(12-18) |
4 |
| poly(rC)500:oligo(dG)10 |
10 |
| Poly(rC):oligo(dG )Template:Primer |
50 |
| HIV-1 Reverse Transcriptase Mutant (K103N/Y181C) |
poly rC/biotin-dG15 |
11 |
| HIV-1 Reverse Transcriptase Mutant (L100I) |
(rC)n.(dG)12-18 |
47 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA)/oligo(dT) |
4 |
| poly(rC)-oligo(dG)(12-18) |
5 |
| HIV-1 Reverse Transcriptase Mutant (L100I/K103N) |
poly(rA).oligo(dT)12-18 |
3 |
| HIV-1 Reverse Transcriptase Mutant (P236L) |
poly(rA)600:oligo(dT)10 |
43 |
| poly(rC)500:oligo(dG)10 |
10 |
| HIV-1 Reverse Transcriptase Mutant (V106A) |
poly(rA)/oligo(dT) |
3 |
| poly(rC)500:oligo(dG)10 |
9 |
| HIV-1 Reverse Transcriptase Mutant (V179D) |
poly(rA)/oligo(dT) |
5 |
| HIV-1 Reverse Transcriptase Mutant (Y181C) |
(poly)rC:(oligo)dG |
7 |
| (rC)n.(dG)12-18 |
69 |
| poly r(A).oligo d(T)16 |
4 |
| poly(rA)-oligo(dT) |
5 |
| poly(rA).oligo(dT)12-18 |
3 |
| poly(rA)600:oligo(dT)10 |
40 |
| poly(rC)-oligo(dG)(12-18) |
10 |
| poly(rC)500:oligo(dG)10 |
93 |
| Poly(rC):oligo(dG )Template:Primer |
46 |
| poly(rC):oligo(dG) |
63 |
| HIV-1 Reverse Transcriptase Mutant (Y181I) |
poly(rA)/oligo(dT) |
5 |
| HIV-1 Reverse Transcriptase Mutant (Y188L) |
poly(rA)/oligo(dT) |
3 |
| poly(rC)500:oligo(dG)10 |
59 |
| HIV-1 Reverse Transcriptase RNase H |
RNA/DNA hybrid |
374 |
| HIV-1 Reverse Transcriptase RNase H Mutant (D67N/K70R/T215F/K219Q) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (L100I/K103N) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (V106A/Y181C) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (Y181C) |
RNA/DNA hybrid |
2 |
| HIV-1 Reverse Transcriptase RNase H Mutant (Y188L) |
RNA/DNA hybrid |
2 |
| HIV-2 Protease |
decapeptide substrate |
7 |
| HIV Protease Peptide Substrate |
13 |
| HIV-1 Protease substrate |
1 |
| Peptide Substrate |
1 |
| HIV-2 Reverse Transcriptase |
poly(rC)-oligo(dG)(12-18) |
3 |
| HIV-2 Reverse Transcriptase RNase H |
RNA/DNA hybrid |
2 |
| HMG-CoA Reductase |
HMG-CoA |
107 |
| Homo sapiens furin (paired basic amino acid cleaving enzyme) (FURIN), mRNA |
to-be-curated |
10 |
| Homoisocitrate Dehydrogenase (HICDH) |
Homoisocitrate |
12 |
| HRH1 |
to-be-curated |
278 |
| HRH2 |
to-be-curated |
26 |
| HRH3 |
to-be-curated |
109 |
| Hsf1 protein |
to-be-curated |
4317 |
| HSP90AA1 protein |
to-be-curated |
128 |
| HTR1A |
to-be-curated |
377 |
| HTR1B |
to-be-curated |
325 |
| HTR1D |
to-be-curated |
217 |
| HTR1E |
to-be-curated |
98 |
| HTR1F |
to-be-curated |
82 |
| HTR2A |
to-be-curated |
492 |
| HTR2B |
to-be-curated |
319 |
| HTR2C |
to-be-curated |
434 |
| HTR3A |
to-be-curated |
215 |
| HTR4 |
to-be-curated |
302 |
| HTR5A |
to-be-curated |
64 |
| HTR6 |
to-be-curated |
299 |
| HTR7 |
to-be-curated |
463 |
| Huntingtin (Huntington disease protein) (HD protein). |
to-be-curated |
92 |
| I-kappa-B Kinase 1 (IKK-alpha) |
I-kappa-B-alpha |
142 |
| I-kappa-B Kinase 2 (IKK-beta) |
Biotinylated I-kappa-B-alpha Peptide Substrate |
22 |
| I-kappa-B-alpha |
151 |
| I-kappa-B Kinase 3 (IKK-epsilon) |
I-kappa-B-alpha |
40 |
| IGF1R |
to-be-curated |
1 |
| IKK-epsilon |
to-be-curated |
8 |
| Imidazoline I2 |
to-be-curated |
28 |
| imipramine |
to-be-curated |
4 |
| Immunophilin FKBP12 |
N-succinyl Ala-Leu-Pro-Phe p-nitroanilide |
79 |
| IMP Cyclohydrolase (IMPCH) |
FAICAR |
3 |
| Indoleamine 2,3-Dioxygenase |
L-tryptophan |
108 |
| Inosine Monophosphate Dehydrogenase Type 1 (IMPDH1) |
IMP |
14 |
| Inosine Monophosphate Dehydrogenase Type 2 (IMPDH2) |
IMP |
40 |
| Inositol Triphosphate |
to-be-curated |
3 |
| INSR |
to-be-curated |
4 |
| Insulin Receptor Tyrosine Kinase (IRK) |
Insulin Kinase Peptide Substrate |
5 |
| peptide 1150 |
1 |
| Peptide Substrate |
8 |
| poly Glu4: Tyr |
77 |
| polyGlu4Tyr |
4 |
| Insulin Receptor-Related Protein (INSRR) |
biotinylated affinity ligand |
6 |
| insulin-degrading enzyme isoform 1 precursor |
to-be-curated |
127 |
| Insulin-like Growth Factor 1 Receptor (IGF-1R) |
biotinylated gastrin substrate |
2 |
| Biotinylated substrate peptide |
160 |
| Peptide Substrate |
8 |
| poly (Glu/Tyr) |
10 |
| integrin alpha 4 precursor |
to-be-curated |
34 |
| integrin alpha-4 precursor |
to-be-curated |
41 |
| integrin alpha-L |
to-be-curated |
15 |
| Integrin alpha1beta1 |
Collagen IV |
5 |
| Integrin alpha2beta1 |
Collagen I |
33 |
| Integrin alpha4beta1 (VLA-4) |
biotinylated CS-1 peptide |
61 |
| Eu-Labeled Human VCAM-1/Fc Chimera |
42 |
| Tritiated 3H Standard Compound A |
44 |
| VCAM-1 |
101 |
| Integrin alpha4beta7 |
MAdCAM-1 |
71 |
| Integrin alpha5beta1 |
Fibronectin |
5 |
| Interleukin |
to-be-curated |
1 |
| interleukin 8 precursor |
to-be-curated |
15 |
| inward rectifier potassium channel 2 |
to-be-curated |
22 |
| IRAK3 |
to-be-curated |
12 |
| ITK |
to-be-curated |
8 |
| JAK1(Kin.Dom.1/JH2 - pseudokinase) |
to-be-curated |
4 |
| JAK2(Kin.Dom.2/JH1 - catalytic) |
to-be-curated |
10 |
| JAK3(Kin.Dom.2/JH1 - catalytic) |
to-be-curated |
14 |
| Janus kinase 2 (a protein tyrosine kinase) |
to-be-curated |
108 |
| JNK1 |
to-be-curated |
7 |
| JNK3 |
to-be-curated |
13 |
| Kallikrein |
benzyloxycarbonyl-Phe-Arg-7-amino-4-methylcoumarin |
27 |
| Pefachrome FVIIa |
27 |
| kallikrein-related peptidase 5 preproprotein |
to-be-curated |
1259 |
| Kappa Opioid Receptor |
[3H]-diprenorphine |
90 |
| [3H]U69593 |
5 |
| kappa opioid receptor [Homo sapiens] |
to-be-curated |
1 |
| karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b |
to-be-curated |
1011 |
| KDR (VEGFR2) |
poly(Glu4, Tyr) |
6 |
| Ketol-acid reductoisomerase |
2-Acetolactate |
3 |
| Cyclopropane, 3 |
1 |
| KIAA1363 |
FP-rhodamine |
1 |
| Kinesin Spindle Protein Eg5 |
ATP |
198 |
| KIT(D816V) |
biotinylated affinity ligand |
23 |
| KIT(V559D T670I) |
biotinylated affinity ligand |
19 |
| Kruppel-like factor 5 |
to-be-curated |
39 |
| Kynurenine Aminotransferase 1/Glutamine Transaminase K |
Kynurenine |
2 |
| Lactate Dehydrogenase |
Lactate |
52 |
| Pyruvate |
16 |
| LacZ protein |
to-be-curated |
294 |
| LANA |
to-be-curated |
1416 |
| LAP4 |
to-be-curated |
214 |
| large T antigen |
to-be-curated |
384 |
| LATS1 |
to-be-curated |
8 |
| LCK |
to-be-curated |
24 |
| Legumain |
Fluorogenic Substrate |
2 |
| Leucine Aminopeptidase |
L-Leucine-para-nitroanilide |
19 |
| leucine aminopeptidase |
to-be-curated |
827 |
| Leukotriene A4 Hydrolase |
Alanine para-nitroanilide |
75 |
| Leukotriene A4 |
42 |
| Leukotriene b1 |
to-be-curated |
1 |
| Leukotriene B4 |
to-be-curated |
24 |
| Leukotriene D4 |
to-be-curated |
17 |
| Leukotriene D4 Alpha |
to-be-curated |
3 |
| Leukotriene D4 Beta |
to-be-curated |
4 |
| likely tRNA 2'-phosphotransferase |
to-be-curated |
19 |
| LIMK1 |
to-be-curated |
5 |
| Lipoxygenase-1 |
Sodium linoleate |
8 |
| Liver Receptor Homolog 1 |
Biotinylated TIF2 Peptide |
23 |
| Liver X Receptor alpha (LXR-alpha) |
biotinylated SRC-1 peptide |
85 |
| GW3965 |
4 |
| Not Available |
18 |
| T0901317 |
39 |
| [3H]T0901317 |
76 |
| Liver X Receptor beta (LXR-beta) |
biotinylated SRC-1 peptide |
137 |
| GW3965 |
4 |
| Not Available |
18 |
| T0901317 |
39 |
| [3H]T0901317 |
74 |
| LKB1 |
to-be-curated |
6 |
| Luteinizing Hormone-Releasing Hormone LHRH |
to-be-curated |
35 |
| LuxS |
to-be-curated |
21 |
| LYN |
to-be-curated |
21 |
| m1-family aminopeptidase |
to-be-curated |
673 |
| M18 aspartyl aminopeptidase |
to-be-curated |
125 |
| Malate Dehydrogenase (pfMDH) |
Oxaloacetic acid |
8 |
| Malate Dehydrogenase, cytoplasmic |
Oxaloacetic acid |
7 |
| Malate Dehydrogenase, mitochondrial |
Oxaloacetic acid |
9 |
| Mammalian Target of Rapamycin (mTOR) |
GFP-4EBP |
1 |
| S6K1 |
91 |
| MAP Kinase Kinase 1 (MEK1) |
biotin-MBP protein |
1 |
| MAP Kinase p38 alpha |
ATF-2-GST |
129 |
| biotinylated ATF2 substrate |
28 |
| biotinylated GST-ATF2 |
56 |
| biotinylated-ATF2 |
60 |
| Epidermal Growth Factor Receptor Peptide (EGFRP) |
12 |
| MK2 |
43 |
| Myelin basic protein |
80 |
| Not Available |
28 |
| Rhodamine-green Labelled Fluoroligand |
33 |
| SKF 86002 |
12 |
| Substrate Peptide T669 |
5 |
| MAP Kinase p38 alpha Mutant (G110A) |
biotinylated GST-ATF2 |
6 |
| MAP Kinase p38 alpha Mutant (G110D) |
biotinylated GST-ATF2 |
6 |
| MAP Kinase p38 beta |
biotinylated GST-ATF2 |
15 |
| MAP Kinase-Interacting Protein Kinase (MNK1) |
MBP |
4 |
| MAP-Microtubule Affinity-Regulating Kinase 3 (MARK3) |
CHKtide Substrate |
1 |
| MAP3K4 |
to-be-curated |
6 |
| MAP3K5 |
to-be-curated |
1 |
| MAP4K1 |
to-be-curated |
14 |
| MAP4K3 |
to-be-curated |
15 |
| MAP4K4 |
to-be-curated |
14 |
| MAP4K4 (HGK) |
Substrate Peptide SerThr 07 |
1 |
| MAP4K5 |
to-be-curated |
18 |
| MAPK-Activated Protein Kinase 2 (MK2) |
Biotinylated GST-LSP1 |
102 |
| HSP27 Peptide |
31 |
| Hsp27 Substrate Peptide |
17 |
| MAPK-Activated Protein Kinase 3 (MK3) |
Peptide Substrate |
4 |
| MAPK-Activated Protein Kinase 5 (MK5) |
Peptide Substrate |
4 |
| MAPKAPK2 |
to-be-curated |
1 |
| MARK1 |
to-be-curated |
8 |
| MARK2 |
to-be-curated |
7 |
| MARK3 |
to-be-curated |
8 |
| MARK4 |
to-be-curated |
7 |
| Matriptase |
Pefachrome tPA |
54 |
| t-Boc-Gln-Ala-Arg-AMC |
14 |
| matrix metalloproteinase 1 |
to-be-curated |
270 |
| matrix metalloproteinase 13 preproprotein |
to-be-curated |
50 |
| Matrix Metalloproteinase-1 (MMP-1) |
Fluorescence-quenched peptide substrate |
1 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
27 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| NFF-2 Substrate |
53 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
2 |
| Matrix Metalloproteinase-10 (MMP-10) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Substrate Peptide |
3 |
| Matrix Metalloproteinase-12 (MMP-12) |
Fluorescence-quenched peptide substrate |
6 |
| MMP Fluorogenic Substrate |
32 |
| MMP Substrate Peptide |
20 |
| Not Available |
5 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
4 |
| Matrix Metalloproteinase-13 (MMP-13) |
5-FAM/QXL 520 Peptide Substrate |
23 |
| Fluorescence-quenched peptide substrate |
1 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
27 |
| MMP Fluorogenic Substrate |
36 |
| MMP Substrate Peptide |
3 |
| MMP-13 Fluorogenic Peptide Substrate |
2 |
| MMP-13 Substrate |
64 |
| Wammp-5 |
51 |
| Matrix Metalloproteinase-14 (MMP-14) |
OmniMMP Substrate |
2 |
| Wammp-5 |
9 |
| Matrix Metalloproteinase-2 (MMP-2) |
5-FAM/QXL520 |
27 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
34 |
| MMP Substrate Peptide |
19 |
| MMP Thioester Substrate |
91 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
39 |
| Matrix Metalloproteinase-3 (MMP-3) |
MMP Fluorogenic Peptide Substrate |
7 |
| MMP Substrate Peptide |
19 |
| MMP-3 Fluorogenic Peptide Substrate |
19 |
| NFF-2 Substrate |
4 |
| Substance P |
62 |
| Matrix Metalloproteinase-7 (MMP-7) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Substrate Peptide |
19 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
7 |
| Matrix Metalloproteinase-8 (MMP-8) |
Fluorescence-quenched peptide substrate |
1 |
| MMP Fluorogenic Peptide Substrate |
18 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| OmniMMP Substrate |
2 |
| Wammp-5 |
7 |
| Matrix Metalloproteinase-9 (MMP-9) |
5-FAM/QXL520 |
27 |
| Fluorogenic Peptide Substrate |
10 |
| MMP Fluorogenic Peptide Substrate |
19 |
| MMP Substrate Peptide |
3 |
| MMP Thioester Substrate |
91 |
| NFF-2 Substrate |
4 |
| OmniMMP Substrate |
2 |
| Unknown |
1 |
| Wammp-5 |
8 |
| MC1R |
to-be-curated |
22 |
| MC3R |
to-be-curated |
24 |
| MC4R |
to-be-curated |
12 |
| MC5R |
to-be-curated |
24 |
| Mcl-1 |
FITC-conjugated-Bim BH3 Peptide |
10 |
| Mcl-1 |
to-be-curated |
1181 |
| MCOLN3 protein |
to-be-curated |
271 |
| MEK Kinase 1 (MEKK1) |
MBP |
1 |
| MEK1 |
to-be-curated |
10 |
| MEK2 |
to-be-curated |
13 |
| MEK3 |
to-be-curated |
3 |
| MEK4 |
to-be-curated |
6 |
| MEK6 |
to-be-curated |
5 |
| melanin-concentrating hormone receptor 1 |
to-be-curated |
85 |
| Melanin-Concentrating Hormone Receptor 1 (MCH1R) |
[125I]-MCH |
21 |
| Melatonin |
to-be-curated |
95 |
| Melatonin 1C |
to-be-curated |
15 |
| MELK |
to-be-curated |
9 |
| MEP2 |
to-be-curated |
18 |
| MERTK |
to-be-curated |
16 |
| MET |
to-be-curated |
10 |
| Metabotropic Glutamate 1a |
to-be-curated |
53 |
| metabotropic glutamate 1b |
to-be-curated |
3 |
| metabotropic glutamate 1c |
to-be-curated |
3 |
| metabotropic glutamate 2/3 |
to-be-curated |
13 |
| metabotropic glutamate 3/1a |
to-be-curated |
3 |
| metabotropic glutamate 3/1c |
to-be-curated |
3 |
| metabotropic glutamate 4a |
to-be-curated |
24 |
| metabotropic glutamate 5a |
to-be-curated |
32 |
| metabotropic glutamate 5b |
to-be-curated |
8 |
| metabotropic glutamate receptor |
to-be-curated |
3 |
| metabotropic glutamate receptor 1 isoform alpha precursor |
to-be-curated |
2 |
| metallo-beta-lactamase IMP-1 |
to-be-curated |
339 |
| Methionine Aminopeptidase (MAP) |
Met-Gly-Met-Met |
14 |
| Met-Pro-pNA |
6 |
| Methionine Aminopeptidase Type 1 (MetAP1) |
Met-Pro-pNA |
5 |
| Octapeptide substrate |
9 |
| Methionine Aminopeptidase Type 2 (MetAP2) |
Met-AMC |
124 |
| Met-Pro-pNA |
5 |
| Octapeptide substrate |
159 |
| Methylthioadenosine Nucleosidase (MTAN) |
MTA |
40 |
| Methylthioadenosine Nucleosidase(MTAN) |
MTA |
14 |
| Methylthioadenosine Phosphorylase (MTAP) |
MTA |
11 |
| mevalonate kinase |
to-be-curated |
954 |
| Mineralocorticoid Receptor (MR) |
Aldosterone |
11 |
| dexamethasone |
8 |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
3 |
| Mint1 |
to-be-curated |
191 |
| Mint1; neuronal munc18-1 binding protein |
to-be-curated |
133 |
| Mitogen- and Stress-Activated Protein Kinase 1 (MSK1) |
Crosstide |
11 |
| Peptide Substrate |
4 |
| Mitogen- and Stress-Activated Protein Kinase 2 (MSK2) |
Peptide Substrate |
4 |
| Mitogen-Activated Protein Kinase 1 |
Myelin basic protein |
4 |
| Mitogen-Activated Protein Kinase 10 (JNK3) |
biotinylated GST-ATF2 |
10 |
| biotinylated-ATF2 |
47 |
| EGF receptor peptide |
29 |
| fluorescently labelled inhibitor |
4 |
| Rhodamine-green Labelled Fluoroligand |
4 |
| Mitogen-activated protein kinase 10 (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (MAP kinase p49 3F12). |
to-be-curated |
362 |
| Mitogen-Activated Protein Kinase 8 (JNK1) |
ATF2 |
45 |
| Biotin-GST-c-JUN |
34 |
| Biotin-labeled pepJIP1 |
45 |
| biotinylated GST-ATF2 |
6 |
| biotinylated-ATF2 |
43 |
| GST-ATF2 |
149 |
| Mitogen-Activated Protein Kinase 9 (JNK2) |
biotinylated affinity ligand |
5 |
| biotinylated GST-ATF2 |
6 |
| GST-ATF2 |
69 |
| mitogen-activated protein kinase kinase kinase 3 isoform 1 |
to-be-curated |
13 |
| mitogen-activated protein kinase kinase kinase kinase 2 |
to-be-curated |
398 |
| Mixed Lineage Kinase 1 (MLK1) |
Myelin basic protein |
37 |
| Mixed Lineage Kinase 2 (MLK2) |
Myelin basic protein |
8 |
| Mixed Lineage Kinase 3 (MLK3) |
Myelin basic protein |
37 |
| MKNK1 |
to-be-curated |
9 |
| MKNK2 |
to-be-curated |
12 |
| MKP-3 |
3-O-methylfluorescein phosphate (OMFP) |
45 |
| ML-IAP-BIR |
AVP-diPhe-FAM |
32 |
| MLCK |
to-be-curated |
6 |
| MLK1 |
to-be-curated |
10 |
| MLK2 |
to-be-curated |
5 |
| MLK3 |
to-be-curated |
7 |
| Monoamine Oxidase Type A (MAO-A) |
5-hydroxy tryptamine creatinine disulfate |
79 |
| kinuramine |
34 |
| Kynuramine |
59 |
| p-Tyramine |
79 |
| Monoamine Oxidase Type B (MAO-B) |
Benzylamine |
3 |
| kinuramine |
34 |
| Kynuramine |
38 |
| MMTP |
16 |
| p-Tyramine |
79 |
| phenylethylamine |
78 |
| Monoamine oxidase type B (MAO-B) Mutant (I199F) |
benzylamine |
5 |
| Monocarboxylate Transporter 1 |
[125I]-pyrrolo[3,4-d]pyridazin-1-one |
8 |
| [3H]-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione |
35 |
| Monoglyceride Lipase (MGL) |
2-arachidonoylglycerol (2-AG) |
21 |
| FP-rhodamine |
1 |
| mothers against decapentaplegic homolog 3 |
to-be-curated |
66 |
| Motilin |
to-be-curated |
4 |
| mouse double minute 2 homolog isoform MDM2 |
to-be-curated |
244 |
| MPI protein |
Mannose-6-phosphate |
462 |
| to-be-curated |
409 |
| MRCK alpha |
S6-peptide |
5 |
| MRCKA |
to-be-curated |
7 |
| MRCKB |
to-be-curated |
7 |
| mRNA interferase toxin, antitoxin is MazE |
to-be-curated |
948 |
| MST1 |
to-be-curated |
9 |
| MST2 |
to-be-curated |
13 |
| MST3 |
to-be-curated |
7 |
| MST4 |
to-be-curated |
6 |
| MTNR1A |
to-be-curated |
91 |
| MTNR1B |
to-be-curated |
69 |
| Mu Opioid Receptor |
[3H]-diprenorphine |
106 |
| [3H]DAMGO |
56 |
| mu opioid receptor |
to-be-curated |
257 |
| MurD |
D-[14C]Glu |
37 |
| muscarinic acetylcholine receptor M4 |
to-be-curated |
4 |
| muscarinic acetylcholine receptor M5 |
to-be-curated |
7 |
| muscarinic M1 receptor (rat) |
to-be-curated |
6 |
| MUSK |
to-be-curated |
10 |
| Myeloid cell leukemia sequence 1 (BCL2-related) |
to-be-curated |
128 |
| MYLK |
to-be-curated |
8 |
| MYLK2 |
to-be-curated |
11 |
| MYO3A |
to-be-curated |
2 |
| MYO3B |
to-be-curated |
3 |
| Myosin Light-Chain Kinase |
Myosin Light-Chain |
18 |
| Myristoyl-CoA:protein N-myristoyltransferase (Nmt) |
GLTISKLFRR-NH2 |
6 |
| N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) |
MUG |
6 |
| n-AChR |
to-be-curated |
151 |
| NACHT, LRR and PYD domains-containing protein 1 isoform 1 |
to-be-curated |
41 |
| NAD-Dependent Deacetylase Sirtuin-1 |
Fluor de Lys-SIRT1 |
21 |
| NAD-Dependent Deacetylase Sirtuin-2 |
Fluor de Lys-SIRT2 |
20 |
| NADPH oxidase 1 |
to-be-curated |
212 |
| NCOA2 protein |
to-be-curated |
349 |
| NDR2 |
to-be-curated |
3 |
| NEK1 |
to-be-curated |
2 |
| NEK2 |
to-be-curated |
6 |
| NEK5 |
to-be-curated |
5 |
| NEK6 |
to-be-curated |
1 |
| NEK7 |
to-be-curated |
4 |
| NEK9 |
to-be-curated |
2 |
| Neuraminidase A |
neuraminidase substrate |
270 |
| Neuraminidase B |
neuraminidase substrate |
181 |
| Neuropeptide Y |
to-be-curated |
11 |
| neuropeptide Y receptor Y1 |
to-be-curated |
303 |
| neuropeptide Y receptor Y2 |
to-be-curated |
185 |
| neuropeptides B/W receptor 1 |
to-be-curated |
214 |
| neurotensin receptor type 1 |
to-be-curated |
185 |
| Neutral Endopeptidase |
DGPA |
29 |
| neutrophil cytosolic factor 1 |
to-be-curated |
1017 |
| Neutrophil Elastase (NE) |
N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin |
33 |
| Suc-Ala-Pro-Ala-MCA |
23 |
| NGF |
to-be-curated |
3 |
| Niacin Receptor GPR109A |
[5, 6-3H]-niacin |
18 |
| Nicotinic Alpha-Bungarotoxin |
to-be-curated |
12 |
| nicotinic central |
to-be-curated |
1 |
| Nitric Oxide Synthase, brain |
L-arginine |
24 |
| Not Available |
30 |
| Nitric Oxide Synthase, brain Mutant (D597N) |
L-arginine |
3 |
| Nitric Oxide Synthase, brain Mutant (D597N/M336V) |
L-arginine |
4 |
| Nitric Oxide Synthase, endothelial |
L-arginine |
24 |
| Not Available |
32 |
| Nitric Oxide Synthase, endothelial Mutant (N368D) |
L-arginine |
3 |
| Nitric Oxide Synthase, inducible |
L-arginine |
14 |
| Not Available |
41 |
| NK1 Receptor |
Substance P |
23 |
| NLK |
to-be-curated |
8 |
| NLRP3 protein |
to-be-curated |
136 |
| NMDA |
to-be-curated |
2 |
| No title found: please add |
to-be-curated |
50 |
| Nociceptin Receptor (ORL1 Receptor) |
leucyl-[3H]nociceptin |
21 |
| [125I]-nociceptin |
89 |
| [125I]Tyr14-Nociceptin |
58 |
| Nociceptin/Orphanin FQ, NOP receptor |
to-be-curated |
5 |
| Norepinephrine transporter |
to-be-curated |
243 |
| Norepinephrine Transporter (NET) |
[125I]RTI-55 |
29 |
| [3H]NE |
6 |
| [3H]Nisoxetine |
19 |
| NPY1R |
to-be-curated |
64 |
| NPY2R |
to-be-curated |
75 |
| NPY5R |
to-be-curated |
49 |
| NS3 |
to-be-curated |
125 |
| NT |
to-be-curated |
30 |
| nuclear receptor coactivator 1 isoform 1 |
to-be-curated |
349 |
| nuclear receptor coactivator 3 isoform a |
to-be-curated |
349 |
| nuclear receptor corepressor 2 isoform 2 |
to-be-curated |
239 |
| Nuclear receptor ROR-alpha (Retinoid-related orphan receptor-alpha) (Nuclear receptor RZR-alpha). |
to-be-curated |
800 |
| nuclear receptor subfamily 1 group I member 2 isoform 1 |
to-be-curated |
126 |
| nuclear receptor subfamily 4, group A, member 1 |
to-be-curated |
281 |
| nuclear receptor subfamily 5, group A, member 1 |
to-be-curated |
802 |
| nucleotide-binding oligomerization domain containing 1 |
to-be-curated |
918 |
| nucleotide-binding oligomerization domain containing 2 |
to-be-curated |
662 |
| OPIATE Kappa 3 |
to-be-curated |
20 |
| OPIATE Mu 2 |
to-be-curated |
2 |
| Opiate non-selective |
to-be-curated |
15 |
| OPIATE Sigma |
to-be-curated |
28 |
| opioid receptor, delta 1 |
to-be-curated |
270 |
| opioid receptor, kappa 1 |
to-be-curated |
853 |
| OPRD1 |
to-be-curated |
229 |
| OPRK1 |
to-be-curated |
224 |
| OPRM1 |
to-be-curated |
308 |
| orexin receptor type 1 |
to-be-curated |
494 |
| Orotidine Monophosphate Decarboxylase (ODCase) |
OMP |
23 |
| ouabain |
to-be-curated |
1 |
| OXTR |
to-be-curated |
31 |
| oxytocin receptor |
to-be-curated |
39 |
| p38-alpha |
to-be-curated |
7 |
| p38-beta |
to-be-curated |
6 |
| p38-gamma |
to-be-curated |
5 |
| p53-Binding Protein HDMX |
p53 Peptide |
25 |
| p53-Binding Protein MDM2 |
6-FAM labeled octapeptide |
20 |
| biotinylated IP3 peptide |
45 |
| biotinylated p53-derived peptide |
9 |
| Fl 9mer |
55 |
| GST-p53 |
1 |
| His6-p53 |
1 |
| Not Available |
6 |
| p53 Peptide |
31 |
| PMDM6-F Peptide |
12 |
| PACAP |
to-be-curated |
87 |
| PACAP-27 |
to-be-curated |
9 |
| PACAP-38 |
to-be-curated |
10 |
| PAK1 |
to-be-curated |
4 |
| PAK2 |
to-be-curated |
3 |
| PAK3 |
to-be-curated |
8 |
| PAK4 |
to-be-curated |
4 |
| PAK6 |
to-be-curated |
3 |
| PAK7/PAK5 |
to-be-curated |
4 |
| Papain |
Z-Phe-Arg-NHNp |
48 |
| PCTK1 |
to-be-curated |
12 |
| PCTK2 |
to-be-curated |
8 |
| PCTK3 |
to-be-curated |
6 |
| PDGFRβ |
poly(Glu4, Tyr) |
1 |
| PDGFR-beta |
biotinylated gastrin substrate |
1 |
| biotinylated peptide substrate |
3 |
| N-biotinyl peptide substrate |
1 |
| Not Available |
15 |
| PDGF Receptor |
12 |
| PDGF Receptor Substrate |
23 |
| PDGFR Peptide Substrate |
11 |
| PDGFR substrate |
46 |
| PDGFR-beta Substrate |
95 |
| Poly (E:Y) |
1 |
| poly(E,Y) |
12 |
| Poly(E:Y) |
390 |
| PDGFRA |
to-be-curated |
22 |
| PDGFRB |
to-be-curated |
23 |
| PDPK1 |
to-be-curated |
6 |
| Pepsin |
Cathepsin D/Pepsin Peptide Substrate |
5 |
| Hemoglobin |
10 |
| Pepsin Substrate Peptide |
11 |
| Peptide Deformylase |
PDF substrate peptide |
12 |
| perilipin-1 |
to-be-curated |
45 |
| perilipin-5 |
to-be-curated |
45 |
| Peripheral-Type Benzodiazepine Receptor |
[3H]PK 11195 |
10 |
| Peroxisome Proliferator-Activated Receptor alpha |
CBP |
89 |
| GW 2331 |
3 |
| Not Available |
88 |
| [3H]GW 2331 |
35 |
| [3H]GW 2433 |
29 |
| [3H]nTZD3 |
37 |
| peroxisome proliferator-activated receptor alpha |
to-be-curated |
6 |
| Peroxisome Proliferator-Activated Receptor delta |
Not Available |
73 |
| TRAP220 |
89 |
| [3H]GW 2433 |
64 |
| Peroxisome Proliferator-Activated Receptor gamma |
biotinylated SRC1 peptide |
3 |
| Not Available |
158 |
| rosiglitazone |
3 |
| [3H]Darglitazone |
37 |
| [3H]rosiglitazone |
67 |
| peroxisome proliferator-activated receptor gamma isoform 2 |
to-be-curated |
45 |
| PfCDPK1 |
MTIP |
29 |
| PFTK1 |
to-be-curated |
7 |
| phencyclidine |
to-be-curated |
1 |
| Phenylethanolamine N-Methyltransferase (PNMT) |
phenylethanolamine |
31 |
| PHKG1 |
to-be-curated |
12 |
| PHKG2 |
to-be-curated |
6 |
| Phorbol ester |
to-be-curated |
1 |
| phosphatase, orphan 1 |
to-be-curated |
71 |
| Phosphodiesterase Type 1 (PDE1B) |
cAMP |
10 |
| Phosphodiesterase Type 10 (PDE10A) |
cAMP |
59 |
| Phosphodiesterase Type 11 (PDE11A) |
cAMP |
10 |
| Phosphodiesterase Type 2 (PDE2A) |
cAMP |
10 |
| Phosphodiesterase Type 3 (PDE3A) |
cAMP |
69 |
| Phosphodiesterase Type 3 (PDE3B) |
cAMP |
81 |
| Phosphodiesterase Type 4 (PDE4A) |
cAMP |
144 |
| Phosphodiesterase Type 4 (PDE4B) |
cAMP |
81 |
| Phosphodiesterase Type 4 (PDE4C) |
cAMP |
2 |
| Phosphodiesterase Type 4 (PDE4D) |
cAMP |
139 |
| Phosphodiesterase Type 5 (PDE5) |
cGMP |
26 |
| Phosphodiesterase Type 5 (PDE5A) |
cGMP |
13 |
| Phosphodiesterase Type 5 (PDE5A) Mutant (661-681 deletion) |
cGMP |
3 |
| Phosphodiesterase Type 5 (PDE5A) Mutant (663-678 deletion) |
cGMP |
3 |
| Phosphodiesterase Type 6 (PDE6) |
cGMP |
7 |
| Phosphodiesterase Type 7 (PDE7B) |
cAMP |
10 |
| Phosphodiesterase Type 8 (PDE8A) |
cAMP |
10 |
| Phosphodiesterase Type 9 (PDE9A) |
cGMP |
10 |
| Phosphoinositide 3-Kinase (PI3K), alpha |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
140 |
| Phosphoinositide 3-Kinase (PI3K), alpha Mutant (E545K) |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
1 |
| Phosphoinositide 3-Kinase (PI3K), alpha Mutant (H1047R) |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
1 |
| Phosphoinositide 3-Kinase (PI3K), beta |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
14 |
| Phosphoinositide 3-Kinase (PI3K), C2beta |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
7 |
| Phosphoinositide 3-Kinase (PI3K), delta |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
8 |
| Phosphoinositide 3-Kinase (PI3K), gamma |
Not Available |
4 |
| Phosphatidylinositol-4,5-bisphosphate (PIP2) |
69 |
| Phosphoinositide 3-Kinase (PI3K), Vps34 |
Phosphatidylinositol-4,5-bisphosphate (PIP2) |
1 |
| phospholipase A2 precursor |
to-be-curated |
334 |
| Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
to-be-curated |
2 |
| Phospholipase A2, major isoenzyme |
beta-pyC-10-PG |
21 |
| Phospholipase A2, membrane associated |
beta-pyC-10-PG |
21 |
| DMPC-DCA Phospholipid Blend |
11 |
| phosphomannomutase 2 |
to-be-curated |
178 |
| phosphomevalonate kinase |
to-be-curated |
840 |
| Phosphorylase Kinase |
Phosphorylase b |
13 |
| photoreceptor-specific nuclear receptor |
to-be-curated |
239 |
| PIK3CA |
to-be-curated |
1 |
| PIM-1 Kinase |
Biotinylated Substrate Peptide |
80 |
| Calf Thymus Histone |
24 |
| GST-BAD |
21 |
| PIM peptide substrate |
5 |
| PIM substrate p21 |
3 |
| S6 kinase/Rsk-2 peptide 2 |
32 |
| S6 Peptide Substrate |
10 |
| PIM-2 Kinase |
Biotinylated Substrate Peptide |
80 |
| PIM peptide substrate |
27 |
| PIM substrate p21 |
3 |
| S6 kinase/Rsk-2 peptide 2 |
32 |
| PIM-3 Kinase |
Biotinylated Substrate Peptide |
2 |
| PIM1 |
to-be-curated |
4 |
| PIM2 |
to-be-curated |
3 |
| PIM3 |
to-be-curated |
6 |
| PIP5K1A |
to-be-curated |
8 |
| PIP5K2B |
to-be-curated |
9 |
| PKAC-alpha |
to-be-curated |
6 |
| PKAC-beta |
to-be-curated |
5 |
| PKC alpha |
to-be-curated |
1 |
| PKC beta |
to-be-curated |
1 |
| PKMYT1 |
to-be-curated |
2 |
| PKN1 |
to-be-curated |
8 |
| PKN2 |
to-be-curated |
7 |
| placental-like alkaline phosphatase preproprotein |
to-be-curated |
849 |
| Plasma Kallikrein |
Chromogenic Substrate S-2302 |
4 |
| Plasmepsin I |
Peptide Substrate |
93 |
| Plasmepsin II |
Peptide Substrate |
96 |
| Plasmepsin Substrate Peptide |
11 |
| Plasmepsin IV |
Plasmepsin Substrate Peptide |
11 |
| Plasmin |
Chromogenic Substrate |
7 |
| Chromogenic Substrate S-2366 |
1 |
| Chromozym-PL |
32 |
| Not Specified |
3 |
| Tos-Gly-Pro-Lys-pNA |
54 |
| Trypsin/Thrombin/Plasmin Chromogenic Substrate |
32 |
| Z-Lys-SBzl |
25 |
| plectin 1 |
to-be-curated |
234 |
| PLK1 |
to-be-curated |
2 |
| PLK3 |
to-be-curated |
3 |
| PLK4 |
to-be-curated |
12 |
| polo-like kinase |
to-be-curated |
400 |
| Polo-Like Kinase 1 |
Biotinylated PLKtide |
21 |
| Cdc25C Substrate Peptide |
41 |
| GST-Cdc25 |
1 |
| PLK Substrate Peptide |
70 |
| PLK1 Substrate Peptide |
6 |
| Ser/Thr 16 Peptide |
4 |
| Polo-like kinase 1 (PlK1) |
Cdc25C |
3 |
| Polo-Like Kinase 2 |
Biotinylated PLKtide |
21 |
| CHK2 Substrate Peptide |
5 |
| Ser/Thr 16 Peptide |
4 |
| Polo-Like Kinase 3 |
Biotinylated PLKtide |
21 |
| Casein |
1 |
| CHK2 Substrate Peptide |
5 |
| PLK Substrate Peptide |
16 |
| Ser/Thr 16 Peptide |
4 |
| Polo-Like Kinase 4 |
Biotinylated Peptide A-A11 |
21 |
| Poly (ADP-ribose) Polymerase-1 (PARP-1) |
biotinylated NAD+ |
25 |
| [3H]NAD+ |
157 |
| [adenylate-32P]-NAD |
44 |
| Poly (ADP-ribose) Polymerase-2 (PARP-2) |
[3H]NAD+ |
16 |
| [adenylate-32P]-NAD |
20 |
| poly(A) binding protein, cytoplasmic 1 |
to-be-curated |
241 |
| polyprotein precursor |
to-be-curated |
126 |
| POsterior Segregation family member (pos-1) |
to-be-curated |
1690 |
| Potassium (voltage dependent) |
to-be-curated |
2 |
| Potassium Channel |
to-be-curated |
1 |
| Potassium channel (ATP modulatory) |
to-be-curated |
2 |
| Potassium Channel (Ca2+ dependent) |
to-be-curated |
1 |
| Potassium channel, Apamin |
to-be-curated |
2 |
| Potassium inwardly-rectifying channel, subfamily J, member 1 |
to-be-curated |
3 |
| potassium voltage-gated channel, KQT-like subfamily, member 2 |
to-be-curated |
127 |
| PPIase Pin1 |
cis-Suc-AEPFpNA |
15 |
| PPP5C protein |
to-be-curated |
127 |
| PPYR1 |
to-be-curated |
49 |
| Pregnane X Receptor |
[N-Methyl-3H]-GW0438X |
12 |
| PRKCD |
to-be-curated |
5 |
| PRKCE |
to-be-curated |
4 |
| PRKCH |
to-be-curated |
3 |
| PRKCQ |
to-be-curated |
9 |
| PRKD1 |
to-be-curated |
7 |
| PRKD2 |
to-be-curated |
8 |
| PRKD3 |
to-be-curated |
8 |
| PRKG1 |
to-be-curated |
2 |
| PRKG2 |
to-be-curated |
2 |
| PRKR |
to-be-curated |
12 |
| PRKX |
to-be-curated |
2 |
| probable DNA dC->dU-editing enzyme APOBEC-3A |
to-be-curated |
732 |
| Progesterone Receptor (PR) |
Progesterone |
27 |
| Promegestone |
2 |
| RU486 (tetramethyl-rhodamine conjugated) |
49 |
| Prokineticin Receptor 1 (PKR1) |
[125I]MIT-1 |
3 |
| Prokineticin Receptor 2 (PKR2) |
[125I]MIT-1 |
3 |
| Prostacyclin (IP) Receptor |
[3H]-Iloprost |
17 |
| Prostaglandin D Synthase |
MonoChloroBimane |
16 |
| Prostaglandin D2 Receptor CRTH2 |
[3H]PGD2 |
75 |
| Prostanoid EP1 Receptor |
[3H]PGE2 |
19 |
| Prostanoid EP2 Receptor |
[3H]PGE2 |
19 |
| Prostanoid EP3 Receptor |
[3H]PGE2 |
19 |
| Prostanoid EP4 Receptor |
[3H]PGE2 |
19 |
| Protein Farnesyltransferase (PFT) |
biotinylated lamin B peptide substrate |
87 |
| H-Ras |
6 |
| Ha-Ras-CVLS |
75 |
| K-Ras C-terminus |
29 |
| K-ras(B) decapeptide |
45 |
| K-RasB peptide substrate |
1 |
| Lamin B peptide substrate |
1 |
| Protein kinase B (Akt 1) |
AKT Substrate Peptide |
28 |
| biotinylated Akt peptide substrate |
352 |
| Biotinylated GSK3 alpha Substrate Peptide |
18 |
| Biotinylated Peptide Substrate |
11 |
| Crosstide |
32 |
| Fluorescent-labeled Crosstide |
19 |
| Histone H1 |
3 |
| S6-peptide |
5 |
| Ser-Thr 6 Peptide |
5 |
| Protein kinase B (Akt 2) |
AKT Substrate Peptide |
17 |
| AKTide-2T |
57 |
| biotinylated Akt peptide substrate |
87 |
| Protein kinase B (Akt 3) |
AKT Substrate Peptide |
12 |
| AKT/PKB/Rac Protein Kinase Substrate |
11 |
| biotinylated Akt peptide substrate |
46 |
| Protein Kinase C |
Lysine-rich histone |
162 |
| PKC Peptide Substrate |
1 |
| Protein Kinase C, alpha |
biotinylated tridecapeptide substrate |
10 |
| Histone H1 |
1 |
| Histone type HL |
15 |
| Lysine-rich histone |
79 |
| Myelin basic protein |
4 |
| Protamine Sulfate |
30 |
| Protein Kinase C, beta I |
biotinylated tridecapeptide substrate |
10 |
| Lysine-rich histone |
39 |
| Protein Kinase C, beta II |
Histone type HL |
15 |
| Lysine-rich histone |
79 |
| Protein Kinase C, delta |
biotinylated tridecapeptide substrate |
10 |
| Histone type HL |
15 |
| Lysine-rich histone |
40 |
| PKC Peptide Substrate |
48 |
| Protein Kinase C, epsilon |
biotinylated tridecapeptide substrate |
10 |
| Histone type HL |
15 |
| Lysine-rich histone |
75 |
| Protein Kinase C, eta |
biotinylated tridecapeptide substrate |
10 |
| Histone type HL |
15 |
| Lysine-rich histone |
40 |
| Protein Kinase C, gamma |
biotinylated neurogranin |
6 |
| Lysine-rich histone |
39 |
| Protein Kinase C, theta |
biotinylated tridecapeptide substrate |
10 |
| MBP |
1 |
| PKC Peptide Substrate |
82 |
| Protein Kinase C, zeta |
biotinylated neurogranin |
6 |
| Biotinylated Peptide Substrate |
24 |
| Lysine-rich histone |
14 |
| protein kinase D1 |
to-be-curated |
18 |
| Protein Kinase YpkA |
Myelin basic protein |
4 |
| protein Mdm4 |
to-be-curated |
20 |
| protein phosphatase 1, catalytic subunit, alpha isoform 3 |
to-be-curated |
127 |
| protein phosphatase methylesterase 1 |
to-be-curated |
1 |
| Protein Tyrosine Phosphatase CD45 |
para-nitrophenyl phosphate (pNPP) |
1 |
| Protein Tyrosine Phosphatase LAR |
para-nitrophenyl phosphate (pNPP) |
1 |
| Protein Tyrosine Phosphatase PTPA |
para-nitrophenyl phosphate (pNPP) |
1 |
| Protein Tyrosine Phosphatase PTPB |
para-nitrophenyl phosphate (pNPP) |
5 |
| Protein Tyrosine Phosphatase TC-PTP |
para-nitrophenyl phosphate (pNPP) |
1 |
| Protein Tyrosine Phosphatase VHR |
para-nitrophenyl phosphate (pNPP) |
1 |
| protein tyrosine phosphatase, non-receptor type 22 (lymphoid) isoform 1 |
to-be-curated |
585 |
| protein tyrosine phosphatase, non-receptor type 7 isoform 2 |
to-be-curated |
792 |
| protein-arginine deiminase type-4 |
to-be-curated |
10 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) |
4-nitrophenyl phosphate (pNPP) |
216 |
| DiFMUP |
57 |
| Fluorescein diphosphate (FDP) |
15 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (G117E) |
Fluorescein diphosphate (FDP) |
1 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (L119V) |
Fluorescein diphosphate (FDP) |
2 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (M114V) |
Fluorescein diphosphate (FDP) |
1 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (V113I) |
Fluorescein diphosphate (FDP) |
1 |
| Protein-Tyrosine Phosphatase 1B (PTP1B) Mutant (V113L/M114V) |
Fluorescein diphosphate (FDP) |
1 |
| Protein-Tyrosine Phosphatase SHP-1 |
DiFMUP |
22 |
| Protein-Tyrosine Phosphatase SHP-2 |
DiFMUP |
34 |
| p-nitrophenyl phosphate |
17 |
| PTAFR |
to-be-curated |
50 |
| Pteridine Reductase 1 (PTR1) |
Dihydrobiopterin (H2B) |
11 |
| PTGDR |
to-be-curated |
14 |
| PTGER1 |
to-be-curated |
9 |
| PTGER2 |
to-be-curated |
14 |
| PTGER3 |
to-be-curated |
64 |
| PTGER4 |
to-be-curated |
12 |
| PTGFR |
to-be-curated |
35 |
| PTGIR |
to-be-curated |
36 |
| PTK2 |
to-be-curated |
3 |
| PTK2B |
to-be-curated |
8 |
| PTK2B protein tyrosine kinase 2 beta |
to-be-curated |
211 |
| PTK6 |
to-be-curated |
10 |
| Purine Nucleoside Phosphorylase (PNP) |
Inosine |
18 |
| Purinergic, P2X |
to-be-curated |
1 |
| Purinergic, P2X4 |
to-be-curated |
9 |
| Purinergic, P2Y |
to-be-curated |
1 |
| putative hexokinase HKDC1 |
to-be-curated |
537 |
| putative potassium channel subunit |
to-be-curated |
1 |
| Quinone Reductase 1 |
2-methyl-1,4-naphthoquinone, 5 |
58 |
| Quinone Reductase 2 (QR2) |
NMeH |
27 |
| Rac1 protein |
to-be-curated |
590 |
| RAD51 |
to-be-curated |
182 |
| RAF-1 |
MEK-1 |
1 |
| RAF1 |
to-be-curated |
10 |
| ras protein |
to-be-curated |
411 |
| Ras-related protein Rab-2A. |
to-be-curated |
245 |
| Receptor Tyrosine Kinase TrkA |
GST-PLC-gamma |
2 |
| PGT |
27 |
| PolyEY |
15 |
| Receptor Tyrosine Kinase TrkB |
Biotinylated Poly(EAY) |
2 |
| RecName: Full=Alkanal monooxygenase alpha chain; AltName: Full=Bacterial luciferase alpha chain |
to-be-curated |
21 |
| RecName: Full=Beta-galactosidase; Short=Beta-gal; AltName: Full=Lactase |
to-be-curated |
28 |
| RecName: Full=BRCA1-associated RING domain protein 1; Short=BARD-1 |
to-be-curated |
20 |
| RecName: Full=Muscarinic acetylcholine receptor M1 |
to-be-curated |
8 |
| RecName: Full=Muscarinic acetylcholine receptor M2 |
to-be-curated |
8 |
| RecName: Full=Muscarinic acetylcholine receptor M3 |
to-be-curated |
9 |
| RecName: Full=Zinc finger protein mex-5 |
to-be-curated |
1676 |
| regulator of G-protein signaling 4 |
to-be-curated |
239 |
| regulator of G-protein signalling 16 |
to-be-curated |
245 |
| Renin |
Angiotensinogen |
10 |
| Green Flourescent Protein (tGFP) |
92 |
| Renin FRET Peptide Substrate |
1 |
| Renin Substrate |
34 |
| Renin Substrate Peptide |
11 |
| tetradecapeptide substrate, TDP |
84 |
| RET |
to-be-curated |
19 |
| RET(M918T) |
to-be-curated |
20 |
| Retinoic Acid Receptor, alpha |
[3H]Retinoic acid |
10 |
| Retinoic Acid Receptor, beta |
[3H]Retinoic acid |
10 |
| Retinoic Acid Receptor, gamma |
[3H]Retinoic acid |
10 |
| Rev |
to-be-curated |
77 |
| RGS7 |
to-be-curated |
234 |
| RGS8 protein |
to-be-curated |
245 |
| Rho-associated, coiled-coil containing protein kinase 2 |
to-be-curated |
206 |
| Rho-kinase (ROCK I) |
Biotinylated Peptide Substrate |
25 |
| ROCK I Peptide Substrate |
4 |
| ROCK I Substrate Peptide |
25 |
| ROCK1 Substrate Peptide |
17 |
| Rho-kinase (ROCK II) |
Fluorescent probe ARC-583 |
8 |
| Kemptide |
4 |
| S6 Peptide Substrate |
1 |
| STK substrate 2-biotin |
7 |
| Ribonuclease H |
RNA/DNA hybrid |
2 |
| Ribonuclease H1 |
RNA/DNA hybrid |
8 |
| Ribosomal S6 Kinase 1 (RSK-1) |
RSK Substrate Peptide |
1 |
| RSK1 Substrate Peptide |
8 |
| Ribosomal S6 Kinase 2 (RSK-2) |
RSK Substrate Peptide |
1 |
| Ribosomal S6 Kinase 3 (RSK-3) |
RSK Substrate Peptide |
1 |
| Ribosomal S6 Kinase 4 (RSK-4) |
RSK Substrate Peptide |
1 |
| RIOK1 |
to-be-curated |
8 |
| RIOK3 |
to-be-curated |
7 |
| RIPK1 |
to-be-curated |
8 |
| RIPK2 |
to-be-curated |
15 |
| RNA polymerase beta subunit (EC 2.7.7.6) |
to-be-curated |
157 |
| ROS1 |
to-be-curated |
6 |
| RPL19A |
to-be-curated |
106 |
| RPS6KA1(Kin.Dom.1 - N-terminal) |
to-be-curated |
8 |
| RPS6KA1(Kin.Dom.2 - C-terminal) |
to-be-curated |
9 |
| RPS6KA2(Kin.Dom.1 - N-terminal) |
to-be-curated |
8 |
| RPS6KA2(Kin.Dom.2 - C-terminal) |
to-be-curated |
7 |
| RPS6KA3(Kin.Dom.1 - N-terminal) |
to-be-curated |
7 |
| RPS6KA4(Kin.Dom.1 - N-terminal) |
to-be-curated |
10 |
| RPS6KA4(Kin.Dom.2 - C-terminal) |
to-be-curated |
3 |
| RPS6KA5(Kin.Dom.1 - N-terminal) |
to-be-curated |
8 |
| RPS6KA5(Kin.Dom.2 - C-terminal) |
to-be-curated |
2 |
| RPS6KA6(Kin.Dom.1 - N-terminal) |
to-be-curated |
6 |
| RPS6KA6(Kin.Dom.2 - C-terminal) |
to-be-curated |
8 |
| Runt-Related Transcription Factor 1 Isoform AML1C |
CBFbeta |
38 |
| Venus-CBFbeta-SMMHC |
94 |
| Runt-Related Transcription Factor 1 Isoform AML1C |
Venus-CBFbeta-SMMHC |
101 |
| S-Adenosylmethionine Decarboxylase (AdoMetDC) |
S-adenosyl-L-[carboxy-14C]methionine |
34 |
| Sarco/endoplasmic Reticulum Ca2+ ATPase 1 |
ATP |
31 |
| SARS Coronavirus 3C-like Protease |
Fluorogenic peptide |
2 |
| fluorogenic substrate peptide |
79 |
| Substrate Peptide |
5 |
| SARS Coronavirus Coronavirus Papain-Like Protease |
SARS-CoV PLpro Substrate Peptide |
24 |
| serine/threonine-protein kinase 33 |
to-be-curated |
224 |
| Serotonin Receptor 1A |
Not Available |
95 |
| [3H]-8-OH-DPAT |
62 |
| Serotonin Receptor 1A |
Not Available |
346 |
| Serotonin Receptor 1B |
[3H]-5-HT |
3 |
| Serotonin Receptor 1D |
[3H]-5-HT |
3 |
| Serotonin Receptor 1E |
Not Available |
126 |
| Serotonin Receptor 2A |
[3H]-Ketanserin |
58 |
| Serotonin Receptor 2B |
[3H]-5-HT |
5 |
| Serotonin Receptor 2C |
[125I]DOI |
4 |
| [3H]-5-HT |
1 |
| Serotonin Receptor 4 |
Not Available |
3 |
| [3H]GR113808 |
7 |
| Serotonin Receptor 6 |
[3H]-LSD |
108 |
| Serotonin Receptor 7 |
[3H]-5-CT |
34 |
| [3H]-LSD |
30 |
| Serotonin Transporter (SERT) |
[125I]RTI-55 |
64 |
| [3H]Citalopram |
8 |
| [3H]Paroxetine |
19 |
| SgK085 |
to-be-curated |
6 |
| Sigma |
to-be-curated |
126 |
| Sigma-1 |
to-be-curated |
19 |
| Sigma-2 |
to-be-curated |
3 |
| signal transducer and activator of transcription 1 isoform alpha |
to-be-curated |
293 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha |
to-be-curated |
67 |
| SLC6A3 |
to-be-curated |
221 |
| SLC6A4 |
to-be-curated |
296 |
| SLK |
to-be-curated |
22 |
| SNARK |
to-be-curated |
11 |
| SNF1LK |
to-be-curated |
11 |
| SNF1LK2 |
to-be-curated |
13 |
| Sodium (Site 1) |
to-be-curated |
2 |
| Sodium (Site 2) |
to-be-curated |
2 |
| Sodium Channel |
to-be-curated |
19 |
| Sodium-Dependent Glucose Cotransporter 1 (SGLT1) |
alpha-methyl-D-glucopyranoside (AMG) |
5 |
| Sodium-Dependent Glucose Cotransporter 2 (SGLT2) |
alpha-methyl-D-glucopyranoside (AMG) |
5 |
| SOMATOSTATIN |
to-be-curated |
4 |
| Sortase A (SrtA) |
Abz-LPETG-Dap(Dnp) |
113 |
| Sphingosine 1-Phosphate Receptor 1 |
Not Available |
8 |
| [32P]S1P |
4 |
| [33P]S1P |
20 |
| sphingosine 1-phosphate receptor 1 |
to-be-curated |
27 |
| Sphingosine 1-Phosphate Receptor 2 |
[32P]S1P |
4 |
| sphingosine 1-phosphate receptor 2 |
to-be-curated |
6 |
| Sphingosine 1-Phosphate Receptor 3 |
Not Available |
8 |
| [32P]S1P |
4 |
| [33P]S1P |
20 |
| sphingosine 1-phosphate receptor 3 |
to-be-curated |
6 |
| Sphingosine 1-Phosphate Receptor 4 |
[32P]S1P |
4 |
| [33P]S1P |
19 |
| Sphingosine 1-Phosphate Receptor 5 |
Not Available |
8 |
| [32P]S1P |
4 |
| [33P]S1P |
19 |
| Sphingosine 1-phosphate receptor Edg-5 (S1P receptor Edg-5) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor 2) (S1P2). |
to-be-curated |
63 |
| sphingosine-1-phosphate receptor 1 |
to-be-curated |
46 |
| Sphingosine-1-phosphate receptor 2 |
to-be-curated |
21 |
| sphingosine-1-phosphate receptor 3 |
to-be-curated |
52 |
| Sphingosine-1-phosphate receptor 4 |
to-be-curated |
107 |
| Sphingosine-1-phosphate receptor 5 |
to-be-curated |
27 |
| Src |
biotinylated gastrin substrate |
24 |
| Biotinylated peptide substrate |
119 |
| biotinylated poly-Glu-Tyr |
9 |
| cdc2 substrate peptide |
168 |
| Gastrin-based substrate |
45 |
| N-biotinyl peptide substrate |
1 |
| Not Specified |
1 |
| Peptide Substrate |
28 |
| Poly (GluTyr ) Substrate |
35 |
| poly(E,Y) |
138 |
| Poly(E:Y) |
296 |
| Poly(Glu,Tyr) |
30 |
| poly-Glu-Ala-Tyr |
16 |
| Src SH2 Binding Substrate |
50 |
| Substrate Peptide Tyr 02 |
1 |
| Src Mutant (S345C) |
Tyr 02 Substrate Peptide |
4 |
| Src Mutant (S345C/T338M) |
Tyr 02 Substrate Peptide |
4 |
| Src Mutant (T338M) |
biotinylated poly-Glu-Tyr |
9 |
| SRMS |
to-be-curated |
10 |
| SRPK1 |
to-be-curated |
7 |
| SRPK2 |
to-be-curated |
6 |
| SSTR1 |
to-be-curated |
184 |
| SSTR2 |
to-be-curated |
310 |
| SSTR3 |
to-be-curated |
197 |
| SSTR4 |
to-be-curated |
200 |
| SSTR5 |
to-be-curated |
274 |
| STAT3 |
to-be-curated |
467 |
| STE20-Like Kinase MST2 |
MBP |
1 |
| Steroid 11-beta-Hydroxylase (CYP11B1) |
deoxycorticosterone |
85 |
| [4-14C]-11-deoxycorticosterone |
16 |
| Steroid 17-alpha-Monooxygenase (CYP17) |
progesterone |
109 |
| Steroid Sulfatase (STS) |
Estrone 3-sulfate |
20 |
| [6,7-3H] E1S |
25 |
| Steroidogenic Factor 1 |
Biotinylated DAX-1 Peptide |
23 |
| Not Available |
24 |
| STK16 |
to-be-curated |
6 |
| STK33 |
to-be-curated |
10 |
| STK36 |
to-be-curated |
11 |
| streptokinase A precursor |
to-be-curated |
2569 |
| Substance K |
to-be-curated |
19 |
| Substance P |
to-be-curated |
36 |
| SUMO-1-specific protease |
to-be-curated |
704 |
| SUMO/sentrin specific peptidase family member 8 |
to-be-curated |
832 |
| SUMO1 activating enzyme subunit 1 |
to-be-curated |
244 |
| SYK |
to-be-curated |
7 |
| T-Cell Protein-Tyrosine Phosphatase (TCPTP) |
4-nitrophenyl phosphate (pNPP) |
43 |
| Fluorescein diphosphate (FDP) |
12 |
| T-Cell Protein-Tyrosine Phosphatase (TCPTP) Mutant (V121L) |
Fluorescein diphosphate (FDP) |
2 |
| t-Plasminogen Activator (tPA) |
Chromogenic Substrate S-2288 |
31 |
| Not Specified |
3 |
| Spectrozyme tPA |
42 |
| tPA/Trypsin Substrate |
5 |
| TACR1 |
to-be-curated |
46 |
| TACR2 |
to-be-curated |
48 |
| TACR3 |
to-be-curated |
33 |
| Tankyrase-1 |
biotinylated NAD+ |
1 |
| TBPS |
to-be-curated |
2 |
| TBXA2R |
to-be-curated |
66 |
| TEC |
to-be-curated |
5 |
| TESK1 |
to-be-curated |
7 |
| TGF-beta Receptor Type-1 |
ALK5 FP probe |
16 |
| TGF-beta receptor type I |
27 |
| TGFBR1 |
to-be-curated |
5 |
| TGFBR2 |
to-be-curated |
6 |
| TGR5 |
Not Available |
9 |
| Thrombin |
benzoyl-Phe-Val-Arg-7-amino-4-methylcoumarin |
27 |
| Boc-Val-Pro-Arg-AMC |
529 |
| Chromogenic Substrate |
11 |
| Chromogenic Substrate Pefachrome TH |
9 |
| Chromogenic Substrate S-2238 |
163 |
| Chromogenic Substrate S-2302 |
105 |
| Chromogenic Substrate S-2366 |
158 |
| Fluorogenic Tripeptide Substrate |
27 |
| MeSO2-D-hexahydrotyrosyl-Gly-Arg-pNA |
54 |
| N-t-Boc-Leu-Arg-Arg-AMC |
13 |
| Not Specified |
3 |
| Pefachrome tPA |
8 |
| Spectozyme TH |
77 |
| Thrombin Fluorogenic Substrate |
9 |
| Thrombin substrate |
38 |
| to-be-curated |
14 |
| Trypsin/Thrombin Chromogenic Substrate |
58 |
| Trypsin/Thrombin/Plasmin Chromogenic Substrate |
32 |
| Trypsin/Thrombin/Tryptase Chromogenic Substrate |
22 |
| Thromboxane A2 Synthase (P450 TxA2) |
Prostaglandin H2 |
20 |
| Thromboxane Alpha |
to-be-curated |
7 |
| Thymidine Kinase |
[3H-methyl]TdR |
58 |
| Thymidine Phosphorylase (TP) |
thymidine |
74 |
| Thymidylate Synthase (TS) |
2'-deoxyuridine-5'-monophosphate (dUMP) |
13 |
| 5,10-Methylenetetrahydrofolate |
222 |
| Thyroid Hormone Receptor (TR-alpha) |
Peptide SRC2-2 |
46 |
| T3 |
119 |
| Thyroid Hormone Receptor (TR-beta) |
Peptide SRC2-2 |
46 |
| T3 |
114 |
| Tie-2 |
Biotinylated Her2 Peptide Substrate |
2 |
| biotinylated peptide substrate |
4 |
| biotinylated poly(Glu-Tyr) |
36 |
| biotinylated synthetic peptide |
17 |
| biotinylated Tie-2 peptide substrate |
48 |
| Her2 Peptide Substrate |
96 |
| poly-Glu-Ala-Tyr |
16 |
| TIE1 |
to-be-curated |
17 |
| TIE2 |
to-be-curated |
12 |
| tissue non-specific alkaline phosphatase precursor |
to-be-curated |
379 |
| tissue-nonspecific alkaline phosphatase precursor |
to-be-curated |
490 |
| TLK1 |
to-be-curated |
3 |
| TLK2 |
to-be-curated |
5 |
| TNF-alpha-Converting Enzyme |
pro-TNF-alpha peptide |
40 |
| TACE Substrate Peptide |
20 |
| TNIK |
to-be-curated |
15 |
| TNK1 |
to-be-curated |
11 |
| TNK2 |
to-be-curated |
6 |
| TNNI3K |
to-be-curated |
14 |
| toll-like receptor 9 |
to-be-curated |
235 |
| TPA: Essential component of the Translocase of the Inner Mitochondrial membrane (TIM23 complex) |
to-be-curated |
145 |
| TPA: Essential protein of the mitochondrial intermembrane space |
to-be-curated |
789 |
| Transcription Factor STAT1 |
c-fos sis inducible element (hSIE) |
11 |
| Transcription Factor STAT1:STAT3 Dimer |
c-fos sis inducible element (hSIE) |
2 |
| Transcription Factor STAT3 |
Ala-Tyr(PO3H2)-Leu-Pro-Gln-Thr-Val-NH2 |
50 |
| beta(Ala)-beta(Ala)-G-pYLPQTV |
2 |
| c-fos sis inducible element (hSIE) |
41 |
| Fluorescent-labeled peptide |
3 |
| transient receptor potential cation channel, subfamily N, member 1 |
to-be-curated |
271 |
| TRH |
to-be-curated |
5 |
| Triacylglycerol Hydrolase |
p-Nitrophenyl laurate |
46 |
| TRKA |
to-be-curated |
12 |
| TRKB |
to-be-curated |
12 |
| TRKC |
to-be-curated |
11 |
| tRNA synthetase (AspRS) |
Aspartate |
3 |
| tRNA synthetase (GlnRS) |
Glutamine |
2 |
| tRNA synthetase (GluRS) |
Glutamate |
6 |
| tRNA synthetase (GlyRS) |
Glycine |
6 |
| tRNA synthetase (IleRS) |
Isoleucine |
21 |
| tRNA synthetase (PheRS) |
Phenylalanine |
53 |
| tRNA synthetase (TyrRS) |
Tyrosine |
4 |
| Trypanothione Reductase (TryR) |
Trypanothione disulfide |
38 |
| Trypsin |
Chromogenic Substrate |
24 |
| Chromogenic Substrate S-2222 |
3 |
| Chromogenic Substrate S-2251 |
39 |
| Chromogenic Substrate S-2266 |
52 |
| Chromogenic Substrate S-2765 |
36 |
| L-BAPNA |
38 |
| Not Available |
5 |
| Not Specified |
3 |
| Spectrozyme TRY |
77 |
| tPA/Trypsin Substrate |
5 |
| Trypsin/Thrombin Chromogenic Substrate |
85 |
| Trypsin/Thrombin/Plasmin Chromogenic Substrate |
32 |
| Trypsin/Thrombin/Tryptase Chromogenic Substrate |
22 |
| Tryptase/Trypsin Chromogenic Substrate |
23 |
| Tryptase |
Chromogenic Substrate |
4 |
| Trypsin/Thrombin/Tryptase Chromogenic Substrate |
22 |
| Tryptase/Trypsin Chromogenic Substrate |
27 |
| TSSK1 |
to-be-curated |
3 |
| TTK |
to-be-curated |
13 |
| tumor necrosis factor (ligand) superfamily, member 10 |
to-be-curated |
20 |
| tumor necrosis factor alpha |
to-be-curated |
910 |
| Tumor Progression Loci-2 Kinase (COT) |
biotin-MEK1-peptide |
12 |
| GST-MEK1 |
78 |
| TXK |
to-be-curated |
8 |
| TYK2(Kin.Dom.2/JH1 - catalytic) |
to-be-curated |
7 |
| type-1 angiotensin II receptor |
to-be-curated |
357 |
| TYRO3 |
to-be-curated |
9 |
| tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
to-be-curated |
52 |
| Tyrosine Kinase ACK1 |
Not Specified |
10 |
| Tyrosine Kinase ALK |
biotinylated affinity ligand |
15 |
| Tyrosine Kinase Axl |
polyGlu4Tyr |
4 |
| Tyrosine Kinase BMX |
Not Available |
1 |
| Tyrosine Kinase BRK |
Not Available |
1 |
| Substrate Peptide Tyr 01 |
1 |
| Tyrosine Kinase BTK |
Not Specified |
1 |
| Tyrosine Kinase c-Kit |
biotinylated affinity ligand |
21 |
| biotinylated gastrin substrate |
1 |
| Biotinylated Her2 Peptide Substrate |
1 |
| biotinylated peptide substrate |
41 |
| biotinylated synthetic peptide |
39 |
| Not Available |
1 |
| Poly (E:Y) |
1 |
| poly(Glu:Tyr) |
12 |
| polyGlu4Tyr |
4 |
| Tyrosine Kinase c-Kit Mutant (N822K) |
biotinylated SB202190 |
7 |
| Tyrosine Kinase c-Kit Mutant (V559D) |
biotinylated affinity ligand |
22 |
| biotinylated SB202190 |
7 |
| Tyrosine Kinase c-Kit Mutant (V559D, V654A) |
biotinylated affinity ligand |
19 |
| Tyrosine Kinase c-Kit Mutant (V559D/T670I) |
biotinylated SB202190 |
7 |
| Tyrosine Kinase c-Met |
biotinylated gastrin substrate |
51 |
| Not Available |
1 |
| poly(Glu/Tyr) |
31 |
| poly(Glu4, Tyr) |
28 |
| Tyrosine Kinase c-Met Mutant (D1228H) |
biotinylated gastrin substrate |
1 |
| Tyrosine Kinase c-Met Mutant (H1094R) |
biotinylated gastrin substrate |
1 |
| Tyrosine Kinase c-Met Mutant (M1250T) |
biotinylated gastrin substrate |
1 |
| Tyrosine Kinase c-Met Mutant (V1092I) |
biotinylated gastrin substrate |
1 |
| Tyrosine Kinase c-Met Mutant (Y1230H) |
biotinylated gastrin substrate |
1 |
| Tyrosine Kinase c-Ret |
biotinylated gastrin substrate |
1 |
| poly Glutamic acid-Tyrosine |
14 |
| Tyrosine Kinase CSF1-R |
biotinylated affinity ligand |
24 |
| Biotinylated Her2 Peptide Substrate |
1 |
| biotinylated peptide substrate |
4 |
| Biotinylated substrate peptide |
22 |
| cFMS |
9 |
| FMS Substrate Peptide |
29 |
| Substrate Peptide Tyr 01 |
1 |
| Tyrosine Kinase CSF1-R Mutant (FGFR KID Chimera) |
cFMS -FGFR Chimera |
7 |
| Tyrosine Kinase CSF1-R Mutant (Tie2 KID Chimera) |
cFMS -Tie-2 Chimera |
7 |
| Tyrosine Kinase CSK |
Substrate Peptide Tyr 02 |
1 |
| Tyrosine Kinase DDR1 |
biotinylated affinity ligand |
24 |
| Tyrosine Kinase DDR2 |
biotinylated affinity ligand |
13 |
| Tyrosine Kinase EPHA3 |
biotinylated affinity ligand |
14 |
| Tyrosine Kinase EPHA6 |
biotinylated affinity ligand |
16 |
| Tyrosine Kinase EPHA7 |
biotinylated affinity ligand |
10 |
| Tyrosine Kinase EPHB3 |
biotinylated affinity ligand |
3 |
| Tyrosine Kinase EphB4 |
biotinylated-polypeptide substrate |
30 |
| Tyrosine Kinase FAK |
Blk/Lyntide |
2 |
| Substrate Peptide Tyr 07 |
1 |
| Tyrosine Kinase FLT3 |
biotinylated affinity ligand |
19 |
| biotinylated peptide substrate |
34 |
| biotinylated synthetic peptide |
8 |
| Not Specified |
1 |
| Poly (E:Y) |
1 |
| poly(Glu:Tyr) |
1 |
| polyGlu4Tyr |
4 |
| Substrate Peptide Tyr 02 |
3 |
| Tyrosine Kinase FLT3 Mutant (D835H) |
biotinylated affinity ligand |
23 |
| Tyrosine Kinase FLT3 Mutant (D835Y) |
biotinylated affinity ligand |
21 |
| Tyrosine Kinase FLT3 Mutant (N841I) |
biotinylated affinity ligand |
22 |
| Tyrosine Kinase FLT3-ITD |
biotinylated affinity ligand |
19 |
| Tyrosine Kinase FRK |
biotinylated affinity ligand |
22 |
| Substrate Peptide Tyr 01 |
1 |
| Tyrosine Kinase FYN |
Not Available |
1 |
| Tyrosine Kinase JAK2 |
Not Specified |
1 |
| Tyrosine Kinase JAK3 |
Biotinylated peptide substrate |
4 |
| Not Specified |
37 |
| Tyrosine Kinase Syk |
Syk Peptide Substrate |
29 |
| Syk SH2 Binding Substrate |
31 |
| Tyrosine Kinase TrkA |
MBP |
1 |
| polyGlu4Tyr |
4 |
| Tyrosine Kinase ZAP-70 |
biotinylated gastrin substrate |
1 |
| N-biotinyl peptide substrate |
1 |
| ZAP-70 Peptide Substrate |
29 |
| ZAP-70 SH2 Binding Substrate |
49 |
| Tyrosine-protein kinase ITK |
poly Glu4: Tyr |
77 |
| SAM68 Peptide Substrate |
2 |
| tyrosine-protein phosphatase non-receptor type 12 isoform 2 |
to-be-curated |
83 |
| Tyrosine-Specific Protein Kinase |
Poly(Glu,Tyr) |
6 |
| Ubiquitin C-terminal Hydrolase L3 (UCH-L3) |
Ub-AMC |
10 |
| Ubiquitin carboxyl-terminal hydrolase BAP1 (BRCA1-associated protein 1) (Cerebral protein 6). |
to-be-curated |
42 |
| ubiquitin-conjugating enzyme E2 N |
to-be-curated |
1563 |
| ubiquitin-conjugating enzyme E2I |
to-be-curated |
323 |
| UDP-3-O-Acyl-GlcNAc Deacetylase (LpxC) |
Not Available |
14 |
| unnamed protein product |
to-be-curated |
19 |
| Uracil-DNA glycosylase (UNG) |
6-Formyluracil, 11 |
6 |
| Urea Amidohydrolase |
Urea |
22 |
| Urokinase (uPA) |
benzyloxycarbonyl-Gly-Gly-Arg-7-amino-4-methylcoumarin |
27 |
| Bz-beta-Ala-Gly-Arg-pNA |
54 |
| Chromogenic Substrate S-2444 |
46 |
| Not Specified |
3 |
| uPA Substrate |
14 |
| uPA Chromogenic Substrate |
95 |
| Urokinase (uPA) Mutant (S190A) |
uPA Substrate |
14 |
| v-rel reticuloendotheliosis viral oncogene homolog A isoform 1 |
to-be-curated |
1000 |
| Valosin-containing protein |
to-be-curated |
124 |
| Vanilloid Receptor 1 (TRPV1, VR1) |
Not Available |
395 |
| Radiolabeled A-778317 |
13 |
| Resiniferatoxin |
50 |
| VASOPRESSIN V1 |
to-be-curated |
9 |
| Vasopressin V1a Receptor |
[3H]vasopressin |
45 |
| vasopressin V1a receptor |
to-be-curated |
34 |
| Vasopressin V2 Receptor |
[3H]vasopressin |
62 |
| VEGFR-1 (Flt-1) |
biotinylated affinity ligand |
21 |
| biotinylated gastrin substrate |
1 |
| biotinylated peptide substrate |
4 |
| N-biotinyl peptide substrate |
1 |
| poly(E,A,Y) |
69 |
| poly-Glu-Ala-Tyr-biotin |
76 |
| polyGluTyr |
32 |
| VEGFR-2 (KDR) |
biotinylated gastrin substrate |
63 |
| biotinylated peptide substrate |
41 |
| biotinylated synthetic peptide |
160 |
| Biotinylated VEGF-R Peptide Substrate |
79 |
| biotinylated VEGFR peptide substrate |
60 |
| Gastrin Peptide Substrate |
70 |
| gastrin substrate |
47 |
| GST-PLC-gamma |
2 |
| Not Available |
15 |
| Poly (E:Y) |
2 |
| poly(E,A,Y) |
111 |
| Poly(E:Y) |
47 |
| poly(Glu4, Tyr) |
28 |
| poly-Glu-Ala-Tyr |
54 |
| poly-Glu-Ala-Tyr-biotin |
76 |
| poly-Glu/Tyr |
158 |
| polyGluTyr |
31 |
| Substrate Peptide Tyr 01 |
1 |
| VEGFR-3 (FLT4) |
biotinylated affinity ligand |
18 |
| biotinylated gastrin substrate |
1 |
| Poly (E:Y) |
1 |
| VEGFR2 |
to-be-curated |
17 |
| VIP |
to-be-curated |
63 |
| VIPR2 |
to-be-curated |
3 |
| Vma11p |
to-be-curated |
2 |
| voltage-dependent T-type calcium channel subunit alpha-1H isoform a |
to-be-curated |
984 |
| WEE1 |
to-be-curated |
6 |
| WEE1 homolog (S. pombe) |
to-be-curated |
38 |
| West Nile Virus (WNV) NS2B-NS3 Protease |
Ac-LKKR-pNA |
21 |
| Boc-Gly-Arg-Arg-AMC |
5 |
| Bz-Nle-Lys-Arg-Arg-AMC |
10 |
| noncovalently bound inhibitor |
2 |
| X-linked inhibitor of apoptosis |
to-be-curated |
427 |
| XBP1 |
to-be-curated |
940 |
| XIAP-BIR3 |
AVP-diPhe-FAM |
37 |
| AVPC-BADAN |
4 |
| Smac-based peptide |
34 |
| Smac-derived peptide |
116 |
| XIAP-Linker-BIR2-BIR3 |
SMAC-1F |
40 |
| YANK2 |
to-be-curated |
4 |
| YES |
to-be-curated |
17 |
| YopH |
to-be-curated |
450 |
| YSK1 |
to-be-curated |
9 |
| Zacopride site-R |
to-be-curated |
2 |
| ZAK |
to-be-curated |
12 |
| ZAP70 |
to-be-curated |
1 |